Obesity and other hyperalimentation

E4_OBESITY_HYPER

obesity: A disorder involving an excessive amount of body fat.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints E4_LOCALADIP E4_OBESITY E4_HYPERALI	35354
6. Filter based on genotype QC (FinnGen only)	34093

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	E4_OBESITY_HYPER
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	E4_LOCALADIP\|E4_OBESITY\|E4_HYPERALI
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Obesity and other hyperalimentation based on the number of shared cases.

Similar with more cases:

Endocrine, nutritional and metabolic diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	34093	22770	11323
Unadjusted period prevalence (%)	7.12	8.08	5.19
Median age at first event (years)	50.60	47.97	55.89

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
35354: Matched controls
340525

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

SGA01

NOMESCO Finland

Emergency treatment

1.8

323.3

6180

36322

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.0

321.7

3804

19145

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

321.6

2694

11855

207

Kela drug reimbursment

Chronic arrhythmias

2.0

321.6

4019

20628

ACC51

NOMESCO Finland

Release of median nerve

2.2

319.8

2811

12620

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.4

318.6

536

812

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.9

318.1

1622

5628

J46

ICD-10 Finland

Status asthmaticus

3.4

317.1

1185

3426

R03DC03

ATC

montelukast; oral

1.8

316.3

5981

35023

I50

ICD-10 Finland

Heart failure

4.0

315.8

924

2261

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

315.2

18299

140535

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.6

315.1

1923

7321

SPAT1240

SPAT

Therapeutic discussion

1.9

313.9

4250

22409

P03

ICPC

Feeling depressed

2.0

313.8

4041

20946

P01AB01

ATC

metronidazole; oral, rectal

1.5

313.3

13869

100421

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

313.0

6233

37036

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

311.6

2661

11800

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

2.0

311.0

4130

21630

C07AB02

ATC

metoprolol; systemic

1.8

309.7

5532

31835

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.6

309.6

8864

57974

B01AA03

ATC

warfarin; systemic

2.0

307.7

5050

25768

J01DB01

ATC

cefalexin; oral

2.3

307.7

30207

246110

J01FA06

ATC

roxithromycin; oral

1.6

307.7

13342

94413

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

307.7

10438

69190

A10BJ02

ATC

liraglutide; parenteral

13.9

307.7

2954

2221

N06AB03

ATC

fluoxetine; oral

2.2

307.7

4950

23188

E66.1

ICD-10 Finland

Drug-induced obesity

92.4

307.7

389

C09CA01

ATC

losartan; oral

1.8

307.7

7910

46921

WX290

NOMESCO Finland

Other blockage of nerve

1.6

307.7

17640

128253

R4190

NOMESCO Finland

Nutritional therapy

5.6

307.7

2487

4541

N05AX12

ATC

aripiprazole; systemic

3.0

307.7

1871

6279

A10BD07

ATC

metformin and sitagliptin; systemic

3.5

307.7

1739

4937

A02BC02

ATC

pantoprazole; systemic

2.0

307.7

24265

178464

J45.9

ICD-10 Finland

Asthma, unspecified

2.5

307.7

8022

35994

P76

ICPC

Depressive disorder

2.3

307.7

2852

12345

N03AX12

ATC

[U] gabapentin; oral

1.9

307.7

5786

31064

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.3

307.7

3891

17582

A10AE05

ATC

insulin detemir; parenteral

3.4

307.7

2357

7097

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.7

307.7

1551

4202

J01MA12

ATC

levofloxacin; systemic

1.8

307.7

5844

33270

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.9

307.7

5369

6062

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.1

307.7

4763

23137

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

5.1

307.7

800

1528

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

22.0

307.7

1099

496

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.8

307.7

1960

7082

205

Kela drug reimbursment

Chronic hypertension

2.8

307.7

9569

40341

C09BA02

ATC

enalapril and diuretics; systemic

2.6

307.7

2563

9939

I50.0

ICD-10 Finland

Congestive heart failure

3.4

307.7

2246

6589

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

4.7

307.7

917

1906

XCK10

NOMESCO Finland

Photography of fundus of eye

2.4

307.7

3250

14015

E65

ICD-10 Finland

Localized adiposity

39.8

307.7

226

J96.1

ICD-10 Finland

Chronic respiratory failure

6.5

307.7

953

1453

A10BJ01

ATC

exenatide; parenteral

13.3

307.7

804

597

E66.0

ICD-10 Finland

Obesity due to excess calories

518.3

307.7

1691

C09DA01

ATC

losartan and diuretics; oral

2.2

307.7

3478

16158

A10AE04

ATC

insulin glargine; parenteral

3.8

307.7

4832

13617

J45

ICD-10 Finland

Asthma

2.1

307.7

3920

19246

OAB72, ,

SPAT

7.5

307.7

816

1076

A10BH01

ATC

sitagliptin; oral

4.4

307.7

4886

11975

R03BA05

ATC

fluticasone; inhalant

1.8

307.7

6642

38122

N06AB04

ATC

citalopram; systemic

2.0

307.7

7923

43242

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

307.7

6362

20082

I50.9

ICD-10 Finland

Heart failure, unspecified

3.2

307.7

4465

14743

A10BX07

ATC

[U] liraglutide

19.5

307.7

1208

616

E66

ICD-10 Finland

Obesity

13.0

307.7

6302

5568

N05AH04

ATC

quetiapine; oral

2.1

307.7

7122

36867

WX723

NOMESCO Finland

CPAP therapy

3.5

307.7

1919

5505

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

307.7

13780

96996

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.3

307.7

871

1986

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.5

307.7

4613

19476

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

307.7

3410

16099

C08CA13

ATC

lercanidipine; oral

2.2

307.7

4629

22143

O24.4

ICD-10 Finland

Diabetes mellitus arising in pregnancy

3.1

307.7

4268

14342

R06.5

ICD-10 Finland

Mouth breathing

2.3

307.7

3492

15218

A08AB01

ATC

orlistat; oral

24.8

307.7

669

265

B01AB05

ATC

enoxaparin; parenteral

2.3

307.7

12344

64512

215

Kela drug reimbursment

Diabetes, non-insulin-treated

4.2

307.7

13147

41911

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

5.5

307.7

1008

1802

N03AX16

ATC

[U] pregabalin

2.0

307.7

8582

47202

C08CA01

ATC

amlodipine; oral

2.0

307.7

12474

71874

J01DA01

ATC

[U] cefalexin

1.7

307.7

21625

165068

E66.01

ICD-10 Finland

Obesity due to excess calories

109.3

307.7

20326

4161

SPAT1254

SPAT

Administration of medicine

2.0

307.7

4820

25313

T90

ICPC

Diabetes non-insulin dependent

4.1

307.7

12210

38919

N05BA04

ATC

oxazepam; oral

1.7

307.7

8949

56806

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

307.7

5771

26803

J01AA02

ATC

doxycycline; systemic

1.8

307.7

26718

217002

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

5.2

307.7

1272

2443

R03BA02

ATC

budesonide; inhalant

1.8

307.7

6326

36668

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.6

307.7

5270

21761

A10BK01

ATC

dapagliflozin; oral

4.0

307.7

3489

9177

C10AA01

ATC

simvastatin; oral

1.8

307.7

12013

75229

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.5

307.7

2955

12200

WX780

NOMESCO Finland

Remote monitoring CPAP

3.7

307.7

2110

5787

SPAT1310

SPAT

Counselling related to known health issue

1.7

307.7

10983

72529

G47.3

ICD-10 Finland

Sleep apnoea

5.7

307.7

15396

40675

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.0

307.7

7090

38066

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

6592

37469

R03BB04

ATC

tiotropium bromide; inhalant

2.4

307.7

3238

13853

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

307.7

10452

65613

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

2.4

307.7

3503

15032

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

+∞

307.7

854

3055, ,

Kela drug reimbursment

14.4

307.7

437

295

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

5.6

307.7

1512

2683

R02

ICPC

Shortness of breath/dyspnoea

2.3

307.7

4842

22402

C03CA01

ATC

furosemide; systemic

3.4

307.7

11708

43097

E11

ICD-10 Finland

Type 2 diabetes mellitus

4.0

307.7

8075

23474

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

2.4

307.7

4447

18941

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

5.1

307.7

13186

35848

EBA00

NOMESCO Finland

Extraction of tooth

1.6

307.7

12558

86001

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

307.7

8268

52252

E66.8

ICD-10 Finland

Other obesity

168.0

307.7

12824

1150

M79.6

ICD-10 Finland

Pain in limb

1.8

307.7

15371

101684

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

9.6

307.7

4945

5680

RD210, ,

NOMESCO Finland

7.3

307.7

1230

1663

A46

ICD-10 Finland

Erysipelas

3.0

307.7

6140

22598

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

307.7

9905

45319

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

307.7

6978

41466

L28

ICPC

Limited function/disability (L)

2.1

307.7

5668

28052

C02AC05

ATC

moxonidine; oral

3.4

307.7

1732

5031

A10BA02

ATC

metformin; oral

5.3

307.7

16337

47121

S97

ICPC

Chronic ulcer skin

3.3

307.7

2289

7061

M25.5

ICD-10 Finland

Pain in joint

1.6

307.7

11307

76798

S18

ICPC

Laceration/cut

1.6

307.7

14953

104931

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

2.2

307.7

3202

14546

R60.9

ICD-10 Finland

Oedema, unspecified

2.6

307.7

1982

7509

A08AA62

ATC

bupropion and naltrexone; systemic

14.1

307.7

464

321

N06AB10

ATC

escitalopram; oral

1.7

307.7

7938

48387

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

6.1

307.7

2679

4499

L17

ICPC

Foot/toe symptom/complaint

1.8

307.7

10178

61692

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.1

307.7

5027

24733

I10

ICD-10 Finland

Essential (primary) hypertension

2.9

307.7

22309

126991

C09AA05

ATC

ramipril; oral

1.8

307.7

6960

41285

T82

ICPC

Obesity

13.3

307.7

4809

3974

358

Kela drug reimbursment

liraglutide

18.0

307.7

433

234

A10BH05

ATC

linagliptin; oral

3.7

307.7

1910

5179

A10BB12

ATC

glimepiride; oral

4.4

307.7

2781

6481

A08AA10

ATC

sibutramine; oral

22.4

307.7

341

148

M10.9

ICD-10 Finland

Gout, unspecified

3.3

307.7

2570

7832

P06

ICPC

Sleep disturbance

2.0

307.7

4601

23422

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.7

307.7

9472

61550

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.5

307.7

2574

10274

M04AA01

ATC

allopurinol; systemic

3.3

307.7

5063

16491

N06AX16

ATC

venlafaxine; oral

2.2

307.7

6240

29884

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.1

307.7

7136

37079

QBJ30

NOMESCO Finland

Correction of abdominal apron

33.4

307.7

1059

315

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

4.6

307.7

1221

2605

A10BG03

ATC

pioglitazone; oral

5.6

307.7

1242

2202

H03AA01

ATC

levothyroxine sodium; systemic

1.8

307.7

8262

49285

N06AX21

ATC

duloxetine; oral

2.3

307.7

4975

22348

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

14608

105227

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

15690

99658

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

307.7

6221

36570

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

3.5

307.7

6993

22625

WX722

NOMESCO Finland

PEEP

5.1

307.7

2501

4981

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.8

307.7

1810

6406

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.2

307.7

4267

20169

K02.1

ICD-10 Finland

Caries of dentine

1.6

307.7

21444

165854

C10AA05

ATC

atorvastatin; oral

1.7

307.7

12235

82350

C07AB07

ATC

bisoprolol; oral

2.0

307.7

16116

99301

SPAT1263

SPAT

Sampling

1.6

307.7

14720

103197

A10BB01

ATC

glibenclamide; oral

4.1

307.7

1088

2643

J45.1

ICD-10 Finland

Nonallergic asthma

2.4

307.7

2695

11116

R60.0

ICD-10 Finland

Localized oedema

2.5

307.7

4630

19212

XG466

NOMESCO Finland

Sleep oxymetry

6.1

307.7

1849

3031

N06AX12

ATC

bupropion; oral

2.5

307.7

3358

13620

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.8

307.7

4923

18758

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

307.7

10887

58019

N02BE01

ATC

paracetamol; systemic, rectal

2.8

307.7

32087

266026

OAB72

NOMESCO Finland

Weight control and weight loss guidance

25.5

307.7

966

374

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

9311

59078

E66.00

ICD-10 Finland

Metabolic syndrome

45.7

307.7

9640

2770

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

3.4

307.7

1325

3864

WX110

NOMESCO Finland

Infiltration anesthesia

1.8

307.7

25880

205107

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

4.8

307.7

5440

12380

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

7459

46158

T83

ICPC

Overweight

5.2

307.7

1344

2565

J01FF01

ATC

clindamycin; systemic

2.0

307.7

10481

58906

162

Kela drug reimbursment

liraglutide

18.4

307.7

1031

555

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

4.1

307.7

1267

3032

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.8

307.7

16379

110209

Z3231

NOMESCO Finland

Registered nurse

1.7

307.7

9152

57621

R5140

NOMESCO Finland

Monitoring the use of the aid

4.8

307.7

6855

16122

L03

ICPC

Low back symptom/complaint

1.7

307.7

9867

63028

C09AA02

ATC

enalapril; systemic

2.2

307.7

6215

29924

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.6

307.7

2135

8135

Z3226

NOMESCO Finland

Physiotherapist

1.9

307.7

6207

34727

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.1

307.7

5502

27464

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

307.7

15611

104720

160

Kela drug reimbursment

exenatide

18.6

307.7

1964

1072

A10BJ06

ATC

semaglutide; parenteral

9.0

307.7

4287

5170

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.2

307.7

5416

26326

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

19697

150607

103

Kela drug reimbursment

Diabetes, insulin-treated

4.3

307.7

13935

44501

L15

ICPC

Knee symptom/complaint

1.9

307.7

8514

48993

A08

ICPC

Swelling

3.1

307.7

1886

6080

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

7.2

307.7

3830

5661

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

2.8

307.7

1854

6562

M17.1

ICD-10 Finland

Other primary gonarthrosis

2.2

307.7

7576

37117

A10BK03

ATC

empagliflozin; oral

4.1

307.7

5022

13095

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.5

307.7

4759

19651

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

3.8

307.7

1590

4146

C03DA01

ATC

spironolactone; oral

3.0

307.7

4714

16708

S76

ICPC

Skin infection other

2.7

307.7

1965

7390

SPAT1262

SPAT

Handing over of treatment supplies

3.2

307.7

8165

28867

A10AC01

ATC

insulin (human); parenteral

3.5

307.7

3456

10264

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

430.4

307.7

1661

E66.9

ICD-10 Finland

Obesity, unspecified

96.6

307.7

7124

887

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

2.0

307.7

7503

41241

H02AB06

ATC

prednisolone; systemic

1.8

307.7

17024

114655

B03BA03

ATC

hydroxocobalamin; parenteral

3.0

307.7

1890

6362

A10BJ05

ATC

dulaglutide; parenteral

8.7

307.7

1460

1671

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.7

307.7

7600

47026

XX_20

NOMESCO Finland

Bioimpedance measurement

32.3

307.7

230

M54.5

ICD-10 Finland

Low back pain

1.8

307.7

13676

86895

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.6

307.7

13155

91288

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.9

307.7

5471

29293

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

307.7

3662

16862

C03AA03

ATC

hydrochlorothiazide; oral

2.8

307.7

3144

11544

R03AC02

ATC

salbutamol; inhalant

2.1

307.7

21678

144660

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.9

307.7

7402

42633

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

1852.9

307.7

890

3051, ,

Kela drug reimbursment

12.4

307.7

912

728

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2972.1

307.7

3097

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

307.7

3297

15682

N02AX02

ATC

tramadol; systemic, rectal

2.2

307.7

16755

97886

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

2.8

307.7

5624

21474

A10BX04

ATC

[U] exenatide

19.9

307.7

938

465

A10AB05

ATC

insulin aspart; parenteral

3.2

307.7

3427

10976

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

10402

51898

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.3

307.7

4187

18851

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.3

307.7

4298

19285

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

5.0

307.7

1654

3284

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.5

307.7

4707

19616

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.3

307.7

3392

15166

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

7.1

307.7

728

1001

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

+∞

307.7

1030

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

10852

72821

A08AA02

ATC

fenfluramine; oral

8.3

307.7

521

616

N06AB06

ATC

sertraline; oral

1.9

306.5

4300

22932

N06AX11

ATC

mirtazapine; oral

1.6

305.9

11401

79333

A28

ICPC

Limited function/disability NOS

1.9

305.5

4355

23345

Z01.8

ICD-10 Finland

Other specified special examinations

1.7

305.3

7644

48297

M03BX02

ATC

tizanidine; oral

1.5

304.0

21740

173920

M01AB05

ATC

diclofenac; systemic, rectal

1.5

302.2

22510

181544

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

301.5

16571

125331

N03AX09

ATC

lamotrigine; oral

2.5

300.8

2073

8360

M10

ICD-10 Finland

Gout

2.9

300.7

1470

4982

SPAT1139

SPAT

Nutrition survey

3.2

300.7

1265

3933

ZXD05

NOMESCO Finland

Urgent procedure

1.6

300.0

10205

69463

K07

ICPC

Swollen ankles/oedema

2.9

298.8

1457

4931

K04.0

ICD-10 Finland

Pulpitis

2.0

298.8

3700

18901

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.9

297.0

4475

24407

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

295.1

7013

43657

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.8

293.7

5350

30922

M01AE02

ATC

naproxen; oral, rectal

1.5

293.7

19626

154240

C09DA06

ATC

candesartan and diuretics; oral

2.3

292.7

2496

11051

SFA30

NOMESCO Finland

Three-surface restoration

1.5

290.1

14248

104959

T07

ICPC

Weight gain

4.4

289.9

753

1684

N05AA02

ATC

levomepromazine; systemic

2.8

288.0

1500

5260

N17.9

ICD-10 Finland

Acute renal failure, unspecified

3.1

286.7

1291

4176

N05CF01

ATC

zopiclone; oral

1.6

286.2

9867

67222

Z02.7

ICD-10 Finland

Issue of medical certificate

2.2

285.2

2525

11351

SPAT1301

SPAT

No procedures

1.6

285.2

10034

68668

M01AH05

ATC

etoricoxib; oral

1.5

284.7

21113

169004

A10AD05

ATC

insulin aspart; parenteral

5.1

284.2

607

1154

C09CA06

ATC

candesartan; oral

1.6

284.2

7709

49579

M79.7

ICD-10 Finland

Fibromyalgia

2.8

283.9

1508

5343

SFA20

NOMESCO Finland

Two-surface restoration

1.5

283.1

20593

164096

O99.2

ICD-10 Finland

Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium

4.0

282.9

820

1992

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.8

282.2

4783

27027

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.3

282.1

2304

10013

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

4.1

281.4

786

1858

A10BX01

ATC

guar gum; oral

3.3

281.1

1132

3427

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.7

280.9

1655

6185

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.9

280.7

4164

22571

S10

ICPC

Boil/carbuncle

2.4

280.3

2123

8929

M10.0

ICD-10 Finland

Idiopathic gout

3.3

278.8

1122

3395

R03AC03

ATC

terbutaline; inhalant

1.8

278.4

4803

27279

O36.6

ICD-10 Finland

Maternal care for excessive fetal growth

2.8

278.3

1453

5101

B01AB04

ATC

dalteparin; parenteral

2.5

276.6

1856

7386

R05FB02

ATC

cough suppressants and expectorants; systemic

1.5

276.4

11422

80877

R06AE07

ATC

cetirizine; oral

1.5

275.6

15282

115028

M48.0

ICD-10 Finland

Spinal stenosis

2.0

275.4

3506

18055

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

274.9

6383

39399

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.7

274.6

5902

35683

SPAT1229

SPAT

Assessment of need for aid

2.3

274.3

2303

10123

A10BG02

ATC

rosiglitazone; oral

5.5

273.7

538

949

W85

ICPC

Gestational diabetes

2.6

272.8

1700

6529

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.8

272.5

4366

24231

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.6

272.3

8423

55836

W84

ICPC

Pregnancy high risk

2.7

271.1

1546

5681

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.9

271.0

3669

19286

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

269.3

23827

196596

R96

ICPC

Asthma

2.0

268.9

3253

16450

C01DA14

ATC

isosorbide mononitrate; oral

2.0

268.3

3471

17964

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

267.6

11522

82166

E78.29

ICD-10 Finland

Other mixed hyperlipidaemia

5.9

267.4

488

802

A02BC01

ATC

omeprazole; systemic

1.6

267.4

8610

57572

JN3AD

NOMESCO Finland

Abdominal CT examination

1.9

266.8

3677

19437

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

265.4

4147

22823

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

265.1

17891

139615

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.9

264.9

3498

18227

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

264.5

8487

56678

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.9

263.7

3797

20357

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

6.0

263.1

473

766

J20

ICD-10 Finland

Acute bronchitis

1.9

263.1

3611

19058

O10.0

ICD-10 Finland

Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium

4.0

262.9

764

1859

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

262.6

4193

23227

B01AF02

ATC

apixaban; oral

2.0

262.2

3314

17009

SFA10

NOMESCO Finland

One-surface restoration

1.5

261.6

19037

150598

A10BD03

ATC

metformin and rosiglitazone; systemic

5.1

261.2

558

1061

AA40B, ,

NOMESCO Finland

9.7

260.3

308

307

Z71.8

ICD-10 Finland

Other specified counselling

1.5

257.1

10646

75145

ZXE10

NOMESCO Finland

More than one and less than three hours

1.5

256.6

11115

79195

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

255.7

8848

60039

O13

ICD-10 Finland

Gestational [pregnancy-induced] hypertension

2.5

253.5

1731

6940

R01AD09

ATC

mometasone; nasal

1.5

251.9

15811

121197

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

2.1

251.3

2449

11420

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

250.6

4366

24809

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.7

248.7

1401

5113

4019X

ICD-9 Finland

Essential hypertension, Unspecified

4.0

248.5

737

1820

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.3

247.2

650

1467

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

247.1

8328

56101

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

246.0

3872

21325

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

3.4

246.0

921

2663

R4110

NOMESCO Finland

Physiotherapy

1.6

245.0

8598

58426

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

244.4

25245

212479

H3600, E113,

ICD-10 Finland

5.6

244.3

469

809

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

3.0

244.3

1162

3874

L16

ICPC

Ankle symptom/complaint

1.8

244.0

3861

21298

B81

ICPC

Anaemia vit B12/folate deficiency

2.9

243.7

1182

3983

A10BH02

ATC

vildagliptin; oral

4.2

243.7

676

1589

K04.08

ICD-10 Finland

Other specified pulpit

2.0

243.4

2909

14624

C09CA03

ATC

valsartan; oral

2.0

242.9

2754

13587

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.0

242.5

2699

13227

N02AA05

ATC

oxycodone; systemic

1.7

241.2

4728

27773

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

240.1

9035

62292

QBJ05

NOMESCO Finland

Other correction of loose or redundant skin of trunk

50.9

239.6

142

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

5.4

238.9

480

864

N06AA09

ATC

amitriptyline; systemic

2.0

237.0

2990

15311

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

236.8

2747

13659

A06AD11

ATC

lactulose; oral

1.8

235.7

3891

21727

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

5.8

235.5

441

743

N02BF01

ATC

gabapentin; oral

2.0

234.7

2743

13675

L90

ICPC

Osteoarthrosis of knee

2.2

234.2

2020

8963

SPAT1260

SPAT

Consultation of another employee

1.7

233.4

5679

35316

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

232.7

2418

11546

K42.0

ICD-10 Finland

Umbilical hernia with obstruction, without gangrene

4.7

232.4

545

1122

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

232.4

7783

52238

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.2

230.8

2062

9281

J01MA02

ATC

ciprofloxacin; systemic

1.5

230.2

11839

86858

H02AB07

ATC

prednisone; oral

1.8

230.2

4257

24569

O24.1

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent

7.7

229.8

327

412

177

Kela drug reimbursment

Insulin glargine 300 U / ml

3.6

228.5

776

2105

SPAT1211

SPAT

Application of soft bandage

2.0

228.1

2797

14175

R53

ICD-10 Finland

Malaise and fatigue

1.6

228.0

7746

52122

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

227.8

2683

13407

M02AA07

ATC

piroxicam; topical

1.5

227.4

10630

76492

A01

ICPC

Pain general/multiple sites

1.9

227.1

2932

15124

C08CA02

ATC

felodipine; oral

2.0

226.5

2508

12256

SPAT1283

SPAT

Restricted health certificate

1.6

226.2

6752

44100

R03BA01

ATC

beclometasone; inhalant

1.7

224.4

4484

26438

J01CF05

ATC

flucloxacillin; systemic

2.2

223.1

2114

9738

A12BA01

ATC

potassium chloride; oral

2.9

222.7

1067

3570

S80.0

ICD-10 Finland

Contusion of knee

2.0

222.6

2647

13267

OAB50, ,

SPAT

2.3

221.5

1823

7929

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

220.4

4062

23400

N02BF02

ATC

pregabalin; oral

2.2

220.3

2054

9400

F34.1

ICD-10 Finland

Dysthymia

2.5

219.9

1432

5608

SPAT1312

SPAT

General health counselling

1.5

219.6

10485

75648

N05BA01

ATC

diazepam; systemic, rectal

1.8

219.2

4022

23140

R03DA04

ATC

theophylline; systemic, rectal

2.5

218.9

1402

5448

A10BX09

ATC

[U] dapagliflozin

5.8

218.2

410

693

R51.80

ICD-10 Finland

Headache

1.6

217.4

5426

33898

R05

ICPC

Cough

1.5

217.1

7829

53283

J01FA09

ATC

clarithromycin; systemic

1.5

216.0

10371

74851

D11

ICPC

Diarrhoea

1.7

215.7

4200

24566

JJA21

NOMESCO Finland

Laparoscopic biopsy of liver

13.4

214.4

206

149

J01CA04

ATC

amoxicillin; systemic

1.5

214.4

28352

246688

WZC30

NOMESCO Finland

Teaching

1.7

212.1

4829

29451

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

212.0

1095

3816

N62

ICD-10 Finland

Hypertrophy of breast

2.4

211.9

1564

6486

N05AX08

ATC

risperidone; systemic

2.0

211.3

2392

11773

H02AB04

ATC

methylprednisolone; systemic

1.7

209.7

4537

27295

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

209.1

4019

23406

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.5

208.9

7787

53307

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

208.8

12475

93690

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.9

207.7

3127

16936

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

207.7

5011

31006

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.7

207.4

4300

25568

TLC00

NOMESCO Finland

Insertion of intrauterine device

2.0

207.4

2471

12383

H3601, E113,

ICD-10 Finland

4.6

207.1

507

1081

D07AC01

ATC

betamethasone; topical

1.4

206.3

11375

84125

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.3

205.6

1625

6943

R5110, ,

SPAT

2.2

205.3

1924

8816

SPAT1255

SPAT

Intravenous administration of medicine

2.1

204.4

2116

10074

C07AG02

ATC

carvedilol; oral

2.3

203.3

1590

6762

WX402

NOMESCO Finland

General anaesthesia

1.5

203.0

6933

46529

N05CD07

ATC

temazepam; oral

1.8

201.2

3082

16775

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

200.6

8958

63549

Z3229

NOMESCO Finland

Other healthcare associate professional

2.0

200.0

2506

12773

L60.0

ICD-10 Finland

Ingrowing nail

2.3

199.8

1614

6958

RD112, ,

NOMESCO Finland

12.8

199.8

197

149

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

2.5

199.0

1373

5521

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.7

198.9

4275

25647

C01AA05

ATC

digoxin; systemic

2.3

197.7

1660

7273

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

197.0

1211

4610

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

196.7

4281

25760

F50.8

ICD-10 Finland

Other eating disorders

7.3

196.7

294

392

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

4.2

196.4

529

1216

D01AC02

ATC

miconazole; topical

2.0

195.9

2252

11137

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.2

195.0

1740

7816

M54

ICD-10 Finland

Dorsalgia

1.7

194.7

4247

25566

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.8

194.1

3001

16374

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

193.8

2191

10768

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

193.8

3219

17950

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

2.6

192.9

1190

4538

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.1

192.7

815

2537

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.9

192.1

2668

14067

UJF32

NOMESCO Finland

Coloscopy

1.5

192.0

7561

52216

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

191.7

7678

53203

B01AF01

ATC

rivaroxaban; oral

1.8

191.5

3361

19045

R06.2

ICD-10 Finland

Wheezing

2.3

190.8

1531

6580

B01AB10

ATC

tinzaparin; parenteral

1.8

190.3

3097

17159

WX320

NOMESCO Finland

Spinalanesthesy

1.5

190.0

7233

49584

C09DA03

ATC

valsartan and diuretics; oral

2.4

189.2

1423

5947

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.6

188.4

5334

34240

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

188.4

2856

15480

C10AA07

ATC

rosuvastatin; oral

1.5

188.2

9085

65278

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.8

185.2

2983

16468

E0000UV, ,

ATC

1.4

185.0

13502

104383

A02BC05

ATC

esomeprazole; systemic

1.4

184.9

12700

97174

S29

ICPC

Skin symptom/complaint other

1.6

184.5

5769

37868

SPAT1216

SPAT

Assessment of functional ability

1.7

183.8

4031

24275

N18.8

ICD-10 Finland

Other chronic renal failure

3.2

183.4

742

2249

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

2.6

182.4

1079

4030

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

181.7

12392

94622

XA420

NOMESCO Finland

Extensive sleep examination

4.4

181.1

469

1046

R73.0

ICD-10 Finland

Abnormal glucose tolerance test

3.0

180.5

832

2722

I50.1

ICD-10 Finland

Left ventricular failure

2.5

180.5

1173

4585

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

180.3

3043

17031

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.7

180.0

3868

23160

K08.3

ICD-10 Finland

Retained dental root

1.9

179.8

2296

11764

WX002

NOMESCO Finland

Sedation and analgesia

1.6

179.8

5553

36327

RD140, ,

NOMESCO Finland

79.7

179.6

N06AX26

ATC

vortioxetine; oral

1.9

179.4

2596

13859

N06AX03

ATC

mianserin; oral

2.3

179.0

1507

6606

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.4

178.6

667

1924

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.0

178.3

2222

11291

P99

ICPC

Psychological disorders other

2.5

177.8

1132

4381

M01AH01

ATC

celecoxib; oral

1.6

177.7

5271

34158

L73.2

ICD-10 Finland

Hidradenitis suppurativa

4.0

176.5

509

1231

R74

ICPC

Upper respiratory infection acute

1.4

175.3

11258

84945

A02BC03

ATC

lansoprazole; oral

1.5

175.2

8386

60009

A03

ICPC

Fever

1.5

172.6

5788

38523

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

172.4

725

2249

SGC10

NOMESCO Finland

Pulp capping

1.8

172.2

3130

17888

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.7

172.0

935

3345

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

171.4

2224

11452

F32

ICD-10 Finland

Depressive episode

2.0

171.2

2027

10115

P29

ICPC

Psychological sympt/compl other

1.9

171.2

2515

13483

N05AF03

ATC

chlorprothixene; systemic

2.7

171.2

959

3484

L30.4

ICD-10 Finland

Erythema intertrigo

3.8

170.4

543

1410

N05AN01

ATC

lithium; oral

2.7

168.3

917

3284

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

167.8

6968

48446

JAF30

NOMESCO Finland

Repair of umbilical hernia using prosthetic material

2.9

166.7

796

2656

Z2446

NOMESCO Finland

Social worker

2.0

166.5

2059

10428

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.8

165.7

2675

14757

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

164.4

7520

53243

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

2.7

164.1

897

3217

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

163.8

3792

23110

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

163.8

4510

28679

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.7

163.6

3256

19069

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

162.4

844

2948

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.6

162.4

948

3516

J01DA09

ATC

[U] cefadroxil

1.4

162.2

8419

61003

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

162.0

4492

28605

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.2

161.2

1504

6867

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

160.7

3616

21872

J01FA10

ATC

azithromycin; systemic

1.4

160.2

19533

162431

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

160.0

1990

10095

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

2.9

159.3

751

2488

J45.8

ICD-10 Finland

Mixed asthma

2.5

159.0

1016

3937

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.5

158.8

1075

4280

201

Kela drug reimbursment

Chronic cardiac insufficiency

2.3

158.3

1208

5075

M01AX17

ATC

nimesulide; oral

1.5

158.1

6588

45760

A10AE06

ATC

insulin degludec; parenteral

2.4

158.0

1160

4791

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

4.3

157.9

420

956

N19

ICD-10 Finland

Unspecified kidney failure

2.7

157.7

895

3272

M01AX05

ATC

glucosamine; oral

1.6

157.7

4760

30893

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.8

157.2

2509

13785

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.5

156.8

6581

45766

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

156.7

6213

42720

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

156.7

3587

21784

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.8

156.3

2601

14470

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.3

156.2

607

1795

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

156.1

8473

61812

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.7

155.0

3019

17565

AN1

Coronary angiography

1.8

155.0

2536

14037

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

154.5

2652

14888

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.9

154.3

1949

9935

M01AB01

ATC

indometacin; systemic, rectal

2.0

154.2

1876

9443

ZY010

NOMESCO Finland

Hospital outpatient

2.0

153.8

1768

8723

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.1

153.8

1650

7941

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

153.5

3565

21723

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.3

153.2

1216

5195

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.9

153.0

762

2602

A10BD20

ATC

metformin and empagliflozin; oral

3.7

152.8

497

1309

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.8

152.0

2550

14215

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

151.8

2147

11358

SPAT1234

SPAT

Support of social functional capacity

2.2

151.8

1358

6096

TQW11

NOMESCO Finland

Vacuum treatment of wound

3.0

151.5

681

2196

J96.0

ICD-10 Finland

Acute respiratory failure

4.3

150.5

401

914

A10AB06

ATC

insulin glulisine; parenteral

4.3

150.5

401

914

L14

ICPC

Leg/thigh symptom/complaint

1.8

150.3

2334

12713

R03AC13

ATC

formoterol; inhalant

2.1

148.9

1487

6967

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

2.0

148.4

1701

8383

R04

ICPC

Breathing problem other

2.3

147.8

1200

5175

ZXD10

NOMESCO Finland

Scheduled procedure

1.4

147.7

11279

86942

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

147.6

13656

108419

H01

ICPC

Ear pain/earache

1.6

147.5

3812

23832

R03AK08

ATC

formoterol and beclometasone; inhalant

2.1

147.1

1431

6637

R03AC12

ATC

salmeterol; inhalant

2.2

147.0

1258

5545

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

145.9

5469

37120

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

145.7

22816

195567

SPAT1377

SPAT

Polysomnography

2.3

145.5

1100

4601

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

145.4

3456

21165

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

145.1

9307

69705

SPAT1094

SPAT

Continuous Positive Airway Pressure

3.9

145.0

429

1057

M01AC06

ATC

meloxicam; systemic, rectal

1.4

144.9

10775

82647

N05AH03

ATC

olanzapine; systemic

1.9

144.9

2010

10564

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

144.6

4718

31097

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

3.4

144.6

526

1492

N03AG01

ATC

valproic acid; systemic, rectal

1.9

144.1

1889

9745

A04

ICPC

Weakness/tiredness general

1.6

143.9

4397

28566

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

3.8

143.9

445

1132

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.4

142.8

994

4007

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

2.6

142.8

885

3379

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.8

142.8

728

2517

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

142.7

8733

64858

SPAT1104

SPAT

Monitoring of emergency patient

1.9

142.5

1874

9677

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.0

142.5

654

2134

D07AC13

ATC

mometasone; topical

1.4

142.2

8804

65502

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

142.0

5783

39882

N06AX05

ATC

trazodone; oral

2.5

141.8

906

3510

CL2S4, ,

SPAT

3.4

141.5

515

1461

ZXA00

NOMESCO Finland

Right side

1.4

141.3

7111

51031

R01AD08

ATC

fluticasone; nasal

1.4

141.0

9211

69127

C03BA11

ATC

indapamide; oral

2.7

140.9

785

2843

E68

ICD-10 Finland

Sequelae of hyperalimentation

42.0

140.7

N05AB03

ATC

perphenazine; systemic, rectal

2.3

140.6

1116

4766

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.2

140.6

1182

5172

J01MA14

ATC

moxifloxacin; systemic

1.7

140.1

2560

14613

XG410

NOMESCO Finland

Flow-volume spirometry

2.3

140.1

1163

5062

R11

ICD-10 Finland

Nausea and vomiting

1.7

140.0

2612

14997

AA1AD

NOMESCO Finland

CT of head and brain

1.4

140.0

7126

51228

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.9

139.7

2036

10865

SPAT1281

SPAT

Other administrative function

1.8

139.7

2405

13497

J02AC01

ATC

fluconazole; systemic

1.3

139.1

13232

105193

E000001, ,

ATC

1.5

138.9

6171

43258

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

138.9

615

1966

C10AB05

ATC

fenofibrate; oral

3.1

138.9

595

1866

40199

ICD-8 Finland

Essential benign hypertension

3.6

138.2

459

1226

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.7

137.9

2655

15376

L08

ICPC

Shoulder symptom/complaint

1.4

137.6

6371

44998

L86

ICPC

Back syndrome with radiating pain

1.9

137.6

1843

9573

A41.9

ICD-10 Finland

Sepsis, unspecified

2.4

137.3

955

3848

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

137.1

2978

17811

SPAT1097

SPAT

Recording of ECG

1.6

136.6

3837

24434

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

136.6

8984

67430

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.2

135.9

558

1706

M79.1

ICD-10 Finland

Myalgia

1.5

135.1

4595

30518

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

2.1

135.1

1316

6105

WX725

NOMESCO Finland

Noninvasive ventilation

1.9

134.9

1679

8509

C02EA02, ,

ATC

2.5

134.7

915

3647

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.6

134.6

841

3223

ZXE00

NOMESCO Finland

One hour or less

1.3

134.5

11943

93849

TFP20

NOMESCO Finland

Cardiodefibrillation

1.9

134.4

1744

8963

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.1

134.2

1324

6172

SPAT1054

SPAT

Examination of peripheral nervous system

3.2

133.8

540

1634

D07BC01

ATC

betamethasone and antiseptics; topical

1.6

133.6

3491

21851

R42

ICD-10 Finland

Dizziness and giddiness

1.4

133.5

6354

45072

SPAT1058

SPAT

PEF monitoring instruction

1.8

133.4

2351

13278

G44.2

ICD-10 Finland

Tension-type headache

1.5

133.2

4442

29373

K77

ICPC

Heart failure

3.3

132.9

520

1544

R50.9

ICD-10 Finland

Fever, unspecified

1.5

132.5

4386

28951

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.9

132.4

1786

9294

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.6

132.3

3119

19036

C08DB01

ATC

diltiazem; oral

2.2

132.1

1121

4922

SPAT1153

SPAT

Removal of sutures

1.4

131.9

8854

66597

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.1

131.7

565

1773

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

2.6

131.4

783

2932

EBA30

NOMESCO Finland

Extraction of root of tooth

2.0

131.1

1587

7964

A08AA01

ATC

phentermine; oral

7.2

130.9

196

262

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

130.7

2438

13988

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.2

130.3

1140

5069

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

2.6

130.1

769

2868

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

130.0

4495

29937

C10AX09

ATC

ezetimibe; oral

1.5

130.0

4070

26537

MCA10

NOMESCO Finland

Lower uterine segment caesarean section

1.6

129.7

3237

20032

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

2.3

129.2

1048

4516

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.7

128.9

2398

13747

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

128.3

2819

16895

R4110, ,

SPAT

1.7

128.2

2460

14223

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

128.0

1643

8409

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

127.6

1603

8145

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

127.5

1709

8874

F50.3

ICD-10 Finland

Atypical bulimia nervosa

5.1

127.5

272

517

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

126.9

1203

5521

SPAT1307

SPAT

Psychosocial counselling and guidance

1.8

126.1

2164

12122

D07XC01

ATC

betamethasone; topical

1.6

126.1

3394

21376

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

125.9

11256

88314

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.2

125.8

1168

5316

K10.3

ICD-10 Finland

Alveolitis of jaws

1.9

125.8

1645

8471

R52.9

ICD-10 Finland

Pain, unspecified

1.6

125.3

2965

18103

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

2.7

125.2

716

2627

O82.10

ICD-10 Finland

Delivery by emergency caesarean section

1.8

125.1

1857

9960

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.2

124.9

1132

5104

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.9

124.9

602

2019

M09AX01

ATC

hyaluronic acid; parenteral

2.2

124.6

1159

5280

N05BA12

ATC

alprazolam; oral

1.6

124.5

2915

17748

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

2.4

124.3

875

3544

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

124.1

7818

58099

KGH10

NOMESCO Finland

Operation for phimosis

2.7

124.0

708

2596

L68.0

ICD-10 Finland

Hirsutism

4.4

123.6

312

682

ZXA05

NOMESCO Finland

Left side

1.4

123.3

6527

47102

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.0

123.2

1319

6336

K04.09

ICD-10 Finland

Pulpit UNS

1.9

123.0

1536

7788

C09CA07

ATC

telmisartan; oral

1.8

122.8

2010

11102

A02BA02

ATC

ranitidine; systemic

1.5

122.2

5007

34465

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.1

122.2

1209

5639

P01

ICPC

Feeling anxious/nervous/tense

1.5

122.2

4188

27812

U04

ICPC

Incontinence urine

2.0

121.4

1331

6449

G04BD12

ATC

mirabegron; oral

1.6

121.3

2910

17820

XF402

NOMESCO Finland

ECG with work load test

1.7

121.2

2681

16088

ZXE20

NOMESCO Finland

More than three and less than five hours

1.6

121.1

3590

23103

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.0

120.1

1427

7112

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

2.2

119.9

1017

4463

K43.0

ICD-10 Finland

Incisional hernia with obstruction, without gangrene

4.2

119.9

325

751

A08AX01

ATC

rimonabant; oral

21.2

119.9

K78

ICPC

Atrial fibrillation/flutter

1.9

119.8

1656

8680

RK320, ,

NOMESCO Finland

4.5

119.8

297

640

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.8

119.1

1801

9710

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

119.1

2858

17498

A10BX02

ATC

repaglinide; oral

3.7

118.9

380

989

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

118.3

6145

44154

D07AD01

ATC

clobetasol; topical

1.5

118.3

4858

33437

C09DA07

ATC

telmisartan and diuretics; oral

2.1

118.2

1167

5439

N06AB05

ATC

paroxetine; oral

1.8

118.0

1895

10404

B02AA02

ATC

tranexamic acid; systemic

1.5

117.8

4709

32241

M02AA10

ATC

ketoprofen; topical

1.5

117.7

4424

29921

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

2.1

117.3

1173

5492

T92

ICPC

Gout

3.0

117.1

543

1782

JDF97

NOMESCO Finland

Other laparoscopic bariatric operation on stomach

+∞

117.1

114

N03AX11

ATC

topiramate; oral

2.3

116.8

897

3776

C07BB07

ATC

bisoprolol and thiazides; systemic

2.2

116.5

1020

4534

CK2S4, ,

SPAT

3.3

116.5

459

1369

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.9

116.2

1575

8203

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.6

116.1

2789

17078

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

115.8

3079

19316

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

4.0

115.4

333

806

O24.9

ICD-10 Finland

Diabetes mellitus in pregnancy, unspecified

2.6

115.2

696

2624

MAC40

NOMESCO Finland

Pharmacological induction or advancement of labor

2.6

115.2

713

2720

SPAT1051

SPAT

Guidance regarding sleep disorders

2.9

115.0

563

1904

K05.31

ICD-10 Finland

Periodontitis pronounced

1.6

114.7

2922

18144

F50.4

ICD-10 Finland

Overeating associated with other psychological disturbances

19.5

114.6

R01AD12

ATC

fluticasone furoate; nasal

1.3

114.4

10435

81827

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.3

114.1

895

3801

L13

ICPC

Hip symptom/complaint

1.5

113.7

4837

33491

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.8

113.6

1688

9051

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.9

113.5

1568

8215

N05CF02

ATC

zolpidem; oral

1.4

113.4

5259

37001

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

2.2

113.4

970

4272

Z2221

NOMESCO Finland

Medical doctor

1.3

112.4

8276

62863

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.4

112.2

827

3419

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

111.9

3559

23232

S20

ICPC

Corn/callosity

2.8

111.7

579

2019

R01AD58

ATC

fluticasone, combinations; nasal

1.4

111.3

8106

61454

G93.2

ICD-10 Finland

Benign intracranial hypertension

7.9

111.2

154

188

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.5

110.9

3537

23101

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

110.4

3863

25727

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

110.1

5123

36047

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

110.0

9011

69492

D10

ICPC

Vomiting

1.7

109.9

2035

11634

Z01.2

ICD-10 Finland

Dental examination

1.3

109.9

14831

122372

M01AH02

ATC

rofecoxib; oral

1.6

109.8

3239

20796

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.8

109.7

1756

9627

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

109.7

3876

25863

C09AA03

ATC

lisinopril; oral

2.1

109.5

1107

5203

MAC10

NOMESCO Finland

Antepartum dilatation of cervical canal

2.3

109.5

819

3408

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.9

109.4

1349

6807

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.8

109.3

1891

10606

J96.9

ICD-10 Finland

Respiratory failure, unspecified

5.0

109.0

235

451

XQ800

NOMESCO Finland

Prick test

1.7

108.9

2403

14394

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

4.7

108.4

251

512

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

108.2

1807

10032

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.7

108.0

2015

11543

N06AA12

ATC

doxepin; systemic

1.9

108.0

1354

6871

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.1

107.9

1136

5420

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.9

107.7

527

1782

A08AA04

ATC

dexfenfluramine; oral

9.5

107.6

129

131

JAH01

NOMESCO Finland

Laparoscopy

1.9

107.6

1453

7556

M15

ICD-10 Finland

Polyarthrosis

2.0

107.6

1287

6427

R29

ICPC

Respiratory symptom/complaint other

1.7

107.4

2006

11494

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

107.1

1234

6082

212

Kela drug reimbursment

Gout

3.0

107.0

478

1536

K85

ICPC

Elevated blood pressure

1.5

107.0

3929

26411

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

106.4

1701

9322

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

2.4

106.3

734

2947

J01DA06

ATC

[U] cefuroxime

1.5

106.0

4184

28527

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.1

105.4

1036

4818

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.8

105.1

529

1816

R99

ICPC

Respiratory disease other

2.7

104.8

585

2120

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.9

104.7

1392

7200

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.6

104.4

643

2447

A99

ICPC

Disease/condition unspecnature/site

1.6

104.4

2562

15752

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

104.2

1834

10335

N97.0

ICD-10 Finland

Female infertility associated with anovulation

2.4

103.5

720

2900

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.2

103.5

925

4145

L03.9

ICD-10 Finland

Cellulitis, unspecified

2.5

103.5

660

2554

A10AB04

ATC

insulin lispro; parenteral

2.1

103.5

974

4455

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.5

103.5

671

2617

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

103.3

2016

11689

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.0

102.8

1126

5450

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.8

102.7

1615

8804

ZXA10

NOMESCO Finland

Bilateral

1.4

102.7

4878

34410

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

0.5

102.5

1004

18859

K73.80

ICD-10 Finland

Non-alcoholic fatty liver (NASH, Non Alcoholic Steatohepatitis)

5.8

102.1

188

312

I83.2

ICD-10 Finland

Varicose veins of lower extremities with both ulcer and inflammation

4.8

102.1

235

477

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

102.0

1751

9794

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.8

101.8

1696

9404

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.2

101.6

860

3770

S21

ICPC

Skin texture symptom/complaint

1.5

101.1

3917

26589

N01

ICPC

Headache

1.5

101.0

3520

23393

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.7

101.0

2222

13292

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.2

100.9

858

3768

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.8

100.9

1494

7996

H3603, E113,

ICD-10 Finland

4.2

100.8

276

643

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

100.7

3013

19386

G04BD04

ATC

oxybutynin; oral, transdermal

1.9

100.3

1267

6443

D07AA02

ATC

hydrocortisone; topical

1.5

100.1

4203

28972

SPAT1059

SPAT

Spirometry at the office

1.9

100.1

1368

7139

N02AJ13

ATC

tramadol and paracetamol; systemic

2.4

100.1

701

2833

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.9

99.9

1365

7122

WX892

NOMESCO Finland

Monitored bed care

1.7

99.5

1970

11463

A10BB07

ATC

glipizide; oral

4.1

99.4

279

662

A10BD15

ATC

metformin and dapagliflozin; oral

3.8

99.2

305

773

N30.0

ICD-10 Finland

Acute cystitis

1.4

98.4

4751

33586

QBJ00

NOMESCO Finland

Liposuction in trunk

4.5

98.3

243

523

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.1

98.3

979

4576

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.6

98.2

593

2235

TK800

NOMESCO Finland

Hemodialysis

2.5

98.1

612

2343

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.7

97.9

2026

11927

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.0

97.8

1105

5407

EBA15

NOMESCO Finland

Extraction of multiple teeth

2.0

97.7

1040

4982

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

97.1

741

3110

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.8

97.0

1442

7725

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.3

96.9

382

1140

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.6

96.8

2722

17265

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.7

96.8

2104

12544

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

2.5

96.7

604

2314

C08CA10

ATC

nilvadipine; oral

2.8

96.7

503

1758

N04BC05

ATC

pramipexole; oral

1.7

96.5

1940

11333

R4180, ,

SPAT

3.7

96.4

311

815

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.6

96.3

325

878

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

96.3

905

4136

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.4

96.1

683

2778

WX111

NOMESCO Finland

Local infiltration anesthesia

2.1

96.1

898

4096

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

2.7

96.0

527

1894

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.6

95.7

554

2045

I48.1

ICD-10 Finland

Persistent atrial fibrillation

2.1

95.6

884

4015

EB1VA, ,

NOMESCO Finland

1.5

95.6

3778

25728

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

95.5

3516

23610

E03.89

ICD-10 Finland

Other specified hypothyroidism

2.0

95.5

1116

5526

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

95.4

1523

8337

E000003, ,

ATC

1.9

95.4

1296

6749

R21

ICPC

Throat symptom/complaint

1.3

95.3

6997

52910

N05AE04

ATC

ziprasidone; systemic

3.9

95.2

281

692

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.9

95.2

1357

7176

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

95.0

3530

23749

D06AX01

ATC

fusidic acid; topical

1.6

94.7

2730

17408

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.5

94.5

599

2311

E87.5

ICD-10 Finland

Hyperkalaemia

3.0

94.5

440

1448

RD160, ,

NOMESCO Finland

8.1

94.1

128

153

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

94.1

948

4450

B01AC04

ATC

clopidogrel; oral

1.5

94.0

3511

23639

I11

ICD-10 Finland

Hypertensive heart disease

5.3

93.4

189

343

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

92.9

497

1763

R52.2

ICD-10 Finland

Other chronic pain

2.0

92.6

1065

5243

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.6

92.6

563

2129

SPAT1252

SPAT

Overall medication plan or its review

1.7

92.5

1625

9144

L12

ICPC

Hand/finger symptom/complaint

1.4

92.4

4696

33460

K04.00

ICD-10 Finland

Hyperemia of pulp

1.8

92.4

1474

8065

M76.6

ICD-10 Finland

Achilles tendinitis

1.8

92.3

1437

7807

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.2

91.9

764

3324

UJD02

NOMESCO Finland

Gastroscopy

1.9

91.9

1216

6278

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

2.0

91.8

984

4724

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

91.7

2677

17112

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

2.3

91.7

696

2914

AA43B, ,

NOMESCO Finland

26.1

91.6

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.1

91.5

899

4180

A29

ICPC

General symptom/complaint other

1.5

91.2

3282

21930

Z72.0

ICD-10 Finland

Tobacco use

2.2

90.9

810

3626

I20.09

ICD-10 Finland

Unstable angina

1.9

90.7

1222

6345

K80.5

ICD-10 Finland

Calculus of bile duct without cholangitis or cholecystitis

2.2

90.7

765

3349

N06AG02

ATC

moclobemide; oral

1.9

90.5

1198

6185

Z50.1

ICD-10 Finland

Other physical therapy

1.8

90.5

1416

7704

Z01.7

ICD-10 Finland

Laboratory examination

1.4

90.3

4185

29332

O61.0

ICD-10 Finland

Failed medical induction of labour

3.1

90.3

386

1210

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.7

90.2

486

1730

SPAT1251

SPAT

Organisation of medication

2.1

90.2

892

4157

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

89.9

3021

19900

O80.8

ICD-10 Finland

Other single spontaneous delivery

1.8

89.9

1404

7634

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

7.7

89.9

127

159

C09BA03

ATC

lisinopril and diuretics; oral

2.5

89.7

570

2202

I42.0

ICD-10 Finland

Dilated cardiomyopathy

2.4

89.5

652

2681

K80.8

ICD-10 Finland

Other cholelithiasis

2.6

89.4

529

1974

K86

ICPC

Hypertension uncomplicated

1.5

89.3

2936

19250

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.7

89.3

1667

9541

H36.01

ICD-10 Finland

Diabetic maculopathy

3.0

89.3

409

1334

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.7

89.1

1864

10998

NG2AA

NOMESCO Finland

Patella X-ray examination

2.2

89.0

759

3337

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

89.0

2820

18346

D01AE15

ATC

terbinafine; topical

1.7

89.0

1808

10585

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.3

89.0

7178

54940

X58

ICD-10 Finland

Exposure to other specified factors

1.4

88.8

4122

28890

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.9

88.7

435

1473

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.7

88.7

1749

10159

R52.0

ICD-10 Finland

Acute pain

2.0

88.6

1014

4984

N05BA06

ATC

lorazepam; systemic, sublingual

1.8

88.5

1289

6861

A05

ICPC

Feeling ill

1.7

88.4

1846

10885

C10AB02

ATC

bezafibrate; oral

3.5

88.4

311

864

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.9

88.3

1175

6077

QDB10, ,

SPAT

2.7

88.0

477

1703

A10BD08

ATC

metformin and vildagliptin; systemic

3.9

87.8

261

646

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.3

87.8

668

2800

OAB42, ,

SPAT

1.5

87.7

2972

19609

A11CC03

ATC

alfacalcidol; systemic

2.4

87.6

635

2606

R06AX27

ATC

desloratadine; oral

1.3

87.4

9189

72860

D05AX52

ATC

calcipotriol, combinations; topical

1.7

87.4

1527

8579

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

87.3

30940

284058

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.8

87.3

1287

6875

R03BA08

ATC

ciclesonide; inhalant

1.5

87.2

2537

16198

S01

ICPC

Pain/tenderness of skin

1.8

87.1

1266

6734

Z2445

NOMESCO Finland

Psychologist

1.9

87.0

1221

6424

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.8

86.9

441

1521

SGB30

NOMESCO Finland

Other complicated root filling

1.4

86.7

3683

25392

J01FA01

ATC

erythromycin; systemic

1.4

86.7

4303

30509

Z71.9

ICD-10 Finland

Counselling, unspecified

1.6

86.7

2047

12450

L29

ICPC

Musculoskeletal sympt/complt other

1.6

86.7

2349

14761

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.2

86.6

719

3127

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.5

86.5

2921

19254

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.6

86.5

509

1895

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

86.2

1194

6254

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

86.0

1043

5230

SPAT1151

SPAT

Treatment of major wounds

3.2

85.7

347

1053

N07BB01

ATC

disulfiram; oral

1.8

85.7

1243

6606

O24.0

ICD-10 Finland

Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent

2.6

85.6

511

1916

SPAT1257

SPAT

Teaching of medicine inhalation technique

2.1

85.5

894

4253

R06AX22

ATC

ebastine; oral

1.4

85.5

5214

38242

P74

ICPC

Anxiety disorder/anxiety state

1.8

85.4

1383

7599

I25.2

ICD-10 Finland

Old myocardial infarction

1.8

85.4

1235

6557

JDF21

NOMESCO Finland

Laparoscopic gastric banding

819.6

85.4

KMAK, ,

NOMESCO Finland

1.2

85.4

16671

142083

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

4.0

85.4

243

583

TQW80

NOMESCO Finland

Local dermatologic skincare

2.2

85.2

762

3415

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.5

85.2

564

2221

O34.2

ICD-10 Finland

Maternal care due to uterine scar from previous surgery

1.7

85.1

1721

10062

JAB30

NOMESCO Finland

Repair of inguinal hernia using prosthetic material

0.5

85.1

651

13349

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

84.8

2013

12256

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.0

84.8

372

1184

D07AB08

ATC

desonide; topical

1.5

84.7

3073

20548

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.9

84.7

1124

5808

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

2.9

84.6

400

1328

E87.6

ICD-10 Finland

Hypokalaemia

2.1

84.2

867

4101

T84.5

ICD-10 Finland

Infection and inflammatory reaction due to internal joint prosthesis

3.0

84.0

387

1266

N06AX22

ATC

agomelatine; oral

2.1

83.9

779

3544

JAF11

NOMESCO Finland

Laparoscopic repair of umbilical hernia

3.9

83.8

251

625

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.4

83.6

593

2410

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

83.6

2018

12338

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

3.3

83.5

324

958

D01AC03

ATC

econazole; topical

1.7

83.4

1510

8566

N05BE01

ATC

buspirone; oral

2.1

83.2

861

4080

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

83.2

2160

13433

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.6

83.1

1823

10882

R04.0

ICD-10 Finland

Epistaxis

1.7

83.1

1741

10272

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.0

83.0

881

4215

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.6

82.9

486

1806

WZC00, ,

SPAT

1.5

82.6

2883

19122

S22

ICPC

Nail symptom/complaint

1.7

82.4

1700

9989

D01

ICPC

Abdominal pain/cramps general

1.4

82.0

3493

24078

G04BD08

ATC

solifenacin; oral

1.7

81.8

1531

8765

D09AB01

ATC

zinc bandage without supplements; topical

2.5

81.6

545

2156

L02

ICPC

Back symptom/complaint

1.5

81.4

2956

19763

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

81.3

2831

18767

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.0

81.0

964

4803

WX110, ,

SPAT

1.6

80.9

1776

10603

D02AE01

ATC

carbamide; topical

1.6

80.9

1807

10836

WZA00

NOMESCO Finland

Concise certificate

1.6

80.7

1912

11632

I26.0

ICD-10 Finland

Pulmonary embolism with mention of acute cor pulmonale

2.5

80.6

528

2070

J01FA15

ATC

telithromycin; oral

1.5

80.5

2809

18626

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

80.4

1410

7927

RD130, ,

NOMESCO Finland

21.8

80.4

C08CA05

ATC

nifedipine; systemic

1.7

80.3

1446

8189

I20.90

ICD-10 Finland

Angina pectoris, unspecified

2.2

80.2

693

3063

N05AH02

ATC

clozapine; systemic

2.4

80.2

569

2313

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

1.8

80.1

1240

6722

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.1

79.9

801

3752

C09DB01

ATC

valsartan and amlodipine; oral

2.0

79.7

858

4125

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

79.7

1002

5085

R05

ICD-10 Finland

Cough

1.3

79.6

6014

45504

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.8

79.6

1139

6028

Z08

ICPC

Social welfare problem

2.7

79.5

425

1507

M54.3

ICD-10 Finland

Sciatica

1.7

79.5

1635

9597

K92.1

ICD-10 Finland

Melaena

1.8

79.5

1214

6553

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

79.5

1566

9088

C07AB03

ATC

atenolol; systemic

1.8

79.4

1193

6408

R05DA01

ATC

ethylmorphine; oral

1.6

79.4

2079

12952

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.6

79.1

1892

11535

R03AK11

ATC

formoterol and fluticasone; inhalant

2.1

79.0

730

3314

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

2.6

78.8

462

1717

SPAT1360

SPAT

Extensive global examination

1.6

78.7

1807

10909

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

2.5

78.4

523

2067

R07.3

ICD-10 Finland

Other chest pain

1.5

78.2

2677

17677

C10AA04

ATC

fluvastatin; oral

1.6

78.2

1778

10707

E03

ICD-10 Finland

Other hypothyroidism

1.7

78.2

1686

10019

UKC02

NOMESCO Finland

Cystoscopy

1.4

78.1

3594

25113

D35.0

ICD-10 Finland

Benign neoplasm: Adrenal gland

2.6

77.9

477

1811

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

77.9

4505

32718

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.8

77.8

1320

7351

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

77.7

2118

13316

-1, ,

NOMESCO Finland

1.3

77.7

10290

83662

SPAT1202

SPAT

Intra-articular injection

2.1

77.7

764

3553

R03BB01

ATC

ipratropium bromide; inhalant

2.1

77.6

765

3560

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.5

77.4

2794

18647

NHQ40

NOMESCO Finland

Amputation of toe

2.8

77.3

394

1363

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.7

77.2

1413

8037

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

2.1

77.2

773

3619

L01

ICPC

Neck symptom/complaint

1.4

77.0

4542

33086

F32.8

ICD-10 Finland

Other depressive episodes

2.4

77.0

535

2155

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

3.0

76.7

338

1079

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

2.0

76.0

861

4216

R60.1

ICD-10 Finland

Generalized oedema

3.6

75.7

253

680

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

4.5

75.6

188

407

104

Kela drug reimbursment

Thyroid insufficiency

1.6

75.5

1817

11092

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

75.4

374

1275

K03.66

ICD-10 Finland

Tooth plaque

1.6

75.4

1998

12479

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.9

75.2

937

4741

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.7

75.1

402

1427

N03AE01

ATC

clonazepam; systemic

1.7

74.9

1504

8770

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.0

74.9

893

4450

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

3.4

74.7

270

764

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

2.4

74.6

527

2139

XA421

NOMESCO Finland

Nocturnal polygraphy

4.1

74.6

208

492

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.9

74.5

1055

5563

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.1

74.4

735

3423

G47.9

ICD-10 Finland

Sleep disorder, unspecified

2.0

74.3

808

3900

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.5

74.2

493

1945

ZX120

NOMESCO Finland

Intravenous

1.5

74.0

2441

15992

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

2.1

73.8

685

3115

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.9

73.7

929

4717

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.7

73.7

1331

7543

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

2.0

73.5

807

3907

R73

ICD-10 Finland

Elevated blood glucose level

2.0

73.5

779

3724

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

1.8

73.4

1084

5792

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

2.4

73.1

524

2140

N91.1

ICD-10 Finland

Secondary amenorrhoea

2.2

72.6

611

2672

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

1.9

72.6

957

4932

L03.3

ICD-10 Finland

Cellulitis of trunk

3.4

72.6

271

783

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.0

72.1

801

3896

J01

ICD-10 Finland

Acute sinusitis

1.6

72.0

1690

10252

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

72.0

951

4904

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.2

71.8

620

2740

F31

ICD-10 Finland

Bipolar affective disorder

2.6

71.8

432

1627

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.0

71.7

831

4101

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.1

71.7

660

2992

S06

ICPC

Rash localized

1.7

71.5

1469

8616

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

1.8

71.5

1027

5440

A97

ICPC

No disease

1.3

71.2

4892

36440

SPAT1325

SPAT

Vaccination

1.3

71.2

8719

70088

F41.09

ICD-10 Finland

UNS Panic Syndrome

1.9

71.0

936

4825

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.2

70.9

595

2599

G04BD07

ATC

tolterodine; oral

1.8

70.9

1057

5664

RD250, ,

NOMESCO Finland

+∞

70.9

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

2.2

70.8

582

2521

N07BA03

ATC

varenicline; oral

1.7

70.8

1424

8307

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.0

70.7

805

3949

C07AB05

ATC

betaxolol; oral

2.3

70.6

557

2372

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.7

70.6

1217

6807

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

1.7

70.5

1350

7772

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.4

70.4

501

2040

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

70.4

1691

10316

C09AA04

ATC

perindopril; oral

1.8

70.3

1145

6298

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.5

70.2

454

1770

NG4AA

NOMESCO Finland

Lower leg X-ray examination

2.0

70.1

836

4167

M01AB55

ATC

diclofenac, combinations; oral

1.6

70.0

1547

9246

T45

ICPC

Metabolic, Observ/health educat/advice/diet

2.6

69.9

402

1480

S17

ICPC

Abrasion/scratch/blister

2.2

69.9

606

2683

K28

ICPC

Limited function/disability (K)

2.4

69.9

479

1918

SPAT1285

SPAT

Provision of consultation response

1.7

69.8

1366

7911

R06AX13

ATC

loratadine; oral

1.3

69.6

4512

33307

WZC30, ,

SPAT

1.7

69.4

1431

8403

N06AA04

ATC

clomipramine; systemic

2.4

69.2

481

1938

N06AA10

ATC

nortriptyline; systemic

2.2

69.1

620

2783

OAB74, ,

SPAT

3.3

69.0

263

770

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.6

69.0

1671

10214

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

69.0

794

3910

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.2

69.0

576

2512

M77.4

ICD-10 Finland

Metatarsalgia

1.6

68.9

1716

10558

M43.1

ICD-10 Finland

Spondylolisthesis

1.8

68.8

1063

5756

-50

ICPC

Medication/prescr/renewal

1.8

68.7

1015

5423

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

68.4

2731

18570

L40.9

ICD-10 Finland

Psoriasis, unspecified

2.4

68.4

461

1832

Z98.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3026782) Osmolality of Urine

7995

50578

1.68

320.02

3.3

2.7

557.57

537.93

mosm/kgh2o

9.45

6905

43341

(3002582) Erythrocytes [#/volume] in Urine

11359

78355

1.58

319.87

3.6

3.1

71.32

81.26

e6/l

0.34

8836

59340

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1600

5506

2.88

318.60

3.6

2.9

25.19

24.49

mmol/l

7.52

1570

5375

(3018095) Leukocytes [#/volume] in Urine

13166

94023

1.56

317.93

4.2

3.5

83.06

82.94

e6/l

0.01

9448

64436

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

30576

265146

1.82

309.68

17.2

11.2

85.83

85.54

ml/min/173m2

1.24

26086

217599

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

32351

282040

2.23

307.65

6.0

4.4

2.66

2.83

mmol/l

226.13

30505

263636

(3012516) Albumin [Mass/volume] in Urine

14843

67763

2.91

307.65

3.7

3.2

235.85

447.72

mg/l

10.24

10373

42442

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4735

22856

2.15

307.65

2.3

0.22

g/l

0.05

4411

21392

(3015377) Calcium [Moles/volume] in Serum or Plasma

12954

86274

1.70

307.65

3.0

3.4

2.34

2.35

mmol/l

14.58

11443

76792

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

31783

276278

2.07

307.65

5.4

4.0

1.27

1.49

mmol/l

307.65

29902

258692

(3036481) Cortisol [Moles/volume] in Serum or Plasma

5434

24434

2.35

307.65

2.1

2.2

340.42

379.75

nmol/l

39.77

4931

22634

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

14095

93157

1.76

307.65

4.3

3.1

51.02

60.96

ng/l

0.47

9261

56405

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

10316

60363

1.91

307.65

2.0

1.7

1.03

1.11

mg/l

1.92

8047

45368

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1629

5236

3.09

307.65

2.4

2.3

145.32

99.77

ug/min

2.69

1001

3171

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17352

100992

2.29

307.65

2.4

1.8

95.08

97.56

pmol/l

9.96

10346

52535

(3009508) Creatinine [Moles/volume] in Urine

15773

75983

2.80

307.65

3.6

3.2

7.95

7.91

mmol/l

0.08

13419

65106

(3022096) Basophils/100 leukocytes in Blood

17087

126400

1.58

307.65

6.6

6.1

0.64

0.69

34.60

16019

118283

(3003396) Base excess in Arterial blood by calculation

5157

26027

2.06

307.65

8.6

7.4

1.40

0.93

mmol/l

12.05

4240

20646

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

4000

13109

3.19

307.65

3.7

3.4

1.85

1.56

mmol/l

4.62

3014

9552

(3001604) Monocytes [#/volume] in Blood

18950

139186

1.67

307.65

6.4

5.9

0.60

0.56

e9/l

74.02

16560

121812

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

6620

38499

1.81

307.65

2.0

1.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18277

132074

1.69

307.65

2.8

2.5

—

(3033658) Prothrombin time (PT) actual/Normal

10157

67464

1.63

307.65

4.4

3.8

93.08

92.60

1.05

9845

65710

(3013512) EKG study

10975

70514

1.72

307.65

4.6

3.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

10404

69732

1.62

307.65

1.7

1.6

1.70

1.34

mmol/l

156.40

8787

59345

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

24636

195193

1.71

307.65

4.0

2.9

56.17

43.22

u/l

80.21

23180

184230

(40760892) CBC W Ordered Manual Differential panel - Blood

17954

131411

1.64

307.65

6.8

6.4

—

(3016244) Insulin [Units/volume] in Serum or Plasma

1215

1323

9.12

307.65

4.1

2.6

41.53

16.97

mu/l

44.41

1167

1225

(3019060) Gas panel - Arterial blood

3204

14528

2.24

307.65

5.2

4.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

19111

125143

2.02

307.65

8.0

6.4

1.21

1.22

mmol/l

27.51

16559

106452

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

5162

26032

2.07

307.65

8.6

7.4

5.34

5.05

kpa

67.45

4952

24876

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6694

33118

2.17

307.65

3.0

2.5

20.81

23.62

53.00

5842

28417

(3021447) Carbon dioxide [Partial pressure] in Venous blood

4412

21099

2.16

307.65

4.7

4.0

5.97

5.81

kpa

18.15

4287

20505

(3031040) Bacteria [#/volume] in Urine by Automated count

23232

183204

1.65

307.65

5.2

4.1

1301.18

1391.52

e6/l

0.10

374

2266

(3013707) Erythrocyte sedimentation rate by Westergren method

25494

206819

1.67

307.65

4.7

3.9

15.60

10.66

mm/h

307.65

23814

192848

(3019069) Monocytes/100 leukocytes in Blood

17797

131421

1.61

307.65

6.9

6.3

8.03

8.43

61.06

16788

123675

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

31763

249154

3.24

307.65

8.8

4.9

42.64

38.65

mmol/mol

307.65

30252

232519

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12138

61029

2.39

307.65

3.4

2.8

1196.33

1150.13

ng/l

0.55

10033

51678

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2675

8568

3.17

307.65

3.8

3.7

24.88

24.74

mmol/l

1.73

2516

7936

(3019550) Sodium [Moles/volume] in Serum or Plasma

33012

285256

2.73

307.65

22.3

13.4

139.69

139.64

mmol/l

3.79

32536

278002

(3027801) Oxygen [Partial pressure] in Arterial blood

5160

26016

2.07

307.65

8.6

7.4

11.04

13.02

kpa

166.12

4938

24852

(3020779) Urea [Moles/volume] in Serum or Plasma

4199

20449

2.11

307.65

9.2

7.7

10.91

8.86

mmol/l

53.24

4007

19564

(3022217) INR in Platelet poor plasma by Coagulation assay

17774

112947

2.04

307.65

16.2

11.9

1.22

1.20

inr

1.81

5093

34123

(3004789) Transferrin [Mass/volume] in Serum or Plasma

7166

35903

2.16

307.65

2.9

2.4

2.48

2.36

g/l

48.08

6625

33280

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1069

2644

3.98

307.65

1.2

27.06

30.84

nmol/l

0.25

(3006504) Eosinophils/100 leukocytes in Blood

17698

130696

1.61

307.65

6.5

6.0

2.78

2.85

3.90

16668

122742

(3024561) Albumin [Mass/volume] in Serum or Plasma

18814

108324

2.44

307.65

5.3

4.7

35.52

36.02

g/l

31.05

17787

100656

(3026008) Bacteria identified in Urine by Culture

12134

78032

1.76

307.65

3.3

2.8

—

(3018418) pH of Serum or Plasma

11241

74343

1.67

307.65

4.7

4.0

7.40

0.71

2137

14207

(3022313) Gas panel - Capillary blood

3124

9616

3.34

307.65

3.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

10210

54776

2.12

307.65

1.7

1.5

20.29

20.40

nmol/l

0.31

9073

47291

(3020682) Albumin/Creatinine [Ratio] in Urine

15594

71047

2.99

307.65

4.5

3.8

11.74

8.90

mg/mmol

8.22

10748

44330

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11606

63169

2.15

307.65

2.6

2.2

3.19

2.80

mg/l

50.97

10271

54015

(3022948) Iron [Moles/volume] in Serum or Plasma

7658

39258

2.12

307.65

2.9

2.4

12.55

14.33

umol/l

3.16

7158

36750

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

4174

13757

3.18

307.65

3.7

3.4

5.29

5.10

kpa

36.62

3974

13030

(3009343) pH of Capillary blood

4137

13574

3.19

307.65

3.7

3.4

7.41

7.42

5.85

472

1854

(3002032) Base excess in Venous blood by calculation

4372

21060

2.14

307.65

4.7

4.0

2.04

1.79

mmol/l

3.98

3751

17990

(3042936) Bacteria identified in Isolate by Culture

6643

35837

1.97

307.65

2.4

2.0

—

(3006315) Basophils [#/volume] in Blood

18998

139472

1.67

307.65

6.4

5.9

0.04

e9/l

7.96

16575

121929

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

27602

207923

2.27

307.65

8.2

7.3

80.91

75.98

u/l

58.79

26391

196343

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28367

222049

2.17

307.65

5.0

4.0

14.58

14.60

pmol/l

0.74

26413

204291

(3023368) Bacteria identified in Blood by Culture

11164

63920

2.00

307.65

4.8

4.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15069

90683

2.05

307.65

3.3

3.2

32.55

32.61

u/l

0.04

14286

86223

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17958

111157

2.13

307.65

3.0

2.2

70.34

885.24

nmol/l

0.50

16651

101435

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

20356

136163

2.04

307.65

5.8

6.1

10.57

10.98

umol/l

5.07

19315

128946

(3013650) Neutrophils [#/volume] in Blood by Automated count

21001

160595

1.64

307.65

9.2

9.0

4.59

3.99

e9/l

252.56

18449

141106

(3012544) pH of Venous blood

4533

21861

2.14

307.65

4.7

4.0

7.37

7.38

0.77

151

(3003458) Phosphate [Moles/volume] in Serum or Plasma

7555

30023

2.81

307.65

6.1

1.08

1.03

mmol/l

34.40

7182

28099

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9331

52134

1.98

307.65

2.0

1.6

29732507.27

38412829.86

pmol/l

0.74

7988

43827

(3007853) Bacteria identified in Skin by Aerobe culture

6243

30812

2.16

307.65

2.0

1.7

—

(3019309) Folate [Moles/volume] in Red Blood Cells

8490

41334

2.29

307.65

2.0

1.7

1205.17

1160.94

nmol/l

4.28

6873

31340

(3044640) Blood type and Crossmatch panel - Blood

13045

85837

1.73

307.65

2.5

2.3

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

32537

285558

2.22

307.65

19.5

12.2

21.30

22.20

mg/l

6.10

29439

220540

(3001122) Ferritin [Mass/volume] in Serum or Plasma

18869

128736

1.88

307.65

3.7

2.8

111.69

110.25

ug/l

0.18

17729

120624

(3013115) Eosinophils [#/volume] in Blood

19542

144269

1.68

307.65

6.8

6.1

0.20

0.19

e9/l

33.59

17311

127890

(3002030) Lymphocytes/100 leukocytes in Blood

18158

135942

1.59

307.65

6.7

6.0

27.27

28.77

73.89

17176

128269

(3026493) Urate [Moles/volume] in Serum or Plasma

13137

67137

2.41

307.65

2.9

2.4

3601.54

3641.61

umol/l

0.04

11581

59701

(1002224) Polysomnography panel

2881

11817

2.47

307.65

1.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

23283

153594

2.35

307.65

6.1

4.4

7.15

6.54

mmol/l

235.12

21850

141866

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

9849

65080

1.63

307.65

2.4

2.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

6243

34419

1.91

307.65

1.9

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

13048

83492

1.80

307.65

2.8

2.5

52.06

63.08

u/l

7.16

12097

77236

(3023103) Potassium [Moles/volume] in Serum or Plasma

33045

286151

2.72

307.65

22.5

13.5

3.97

3.95

mmol/l

41.29

32527

278309

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

31924

278152

2.09

307.65

5.4

4.0

4.45

4.75

mmol/l

307.65

30193

261376

(3037467) Urinalysis macro (dipstick) panel - Urine

24564

192912

1.74

307.65

5.0

4.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

31044

266410

2.00

307.65

4.9

3.6

1.61

1.25

mmol/l

307.65

28993

247997

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

17408

113153

1.95

307.65

7.4

5.8

1.21

mmol/l

22.02

16134

103622

(3019198) Lymphocytes [#/volume] in Blood

19382

144006

1.66

307.65

6.5

5.9

2.04

1.94

e9/l

11.21

17307

128785

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

31678

262700

2.55

307.65

6.2

4.6

2.11

2.06

mu/l

0.14

29850

244059

(3016502) Oxygen saturation in Arterial blood

4600

23250

2.04

307.65

9.0

7.8

94.68

96.05

38.34

4457

22350

(3012095) Magnesium [Moles/volume] in Serum or Plasma

8462

39232

2.42

307.65

3.2

3.6

0.82

mmol/l

0.00

8004

36819

(3018010) Neutrophils/100 leukocytes in Blood

17921

133984

1.58

307.65

6.5

5.8

58.59

56.62

107.65

16931

126372

(3024354) Oxygen [Partial pressure] in Venous blood

3626

17167

2.15

307.65

4.0

3.3

4.78

4.64

kpa

3.20

3505

16622

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1577

4653

3.37

307.65

1.9

2.3

1.05

0.80

nmol/l

25.27

1258

3973

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

31837

268555

2.43

307.65

6.1

4.0

6.38

5.78

mmol/l

307.65

29815

248361

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3525

17547

2.04

306.52

4.6

3.9

103.29

85.60

ng/l

17.25

3080

15390

(3000991) Gas panel - Venous blood

3850

19779

1.98

306.33

10.2

8.6

—

(40768797) Stomach Pathology biopsy report

6091

36298

1.74

301.49

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

17928

138256

1.51

294.23

4.3

3.4

0.00

estimate

0.11

3945

27554

(3030467) Casts [#/volume] in Urine by Automated count

10440

71723

1.57

293.49

3.5

3.0

0.48

0.37

e6/l

4.30

8062

53771

(3009261) Glucose [Presence] in Urine by Test strip

18060

139715

1.50

290.22

4.3

3.4

0.01

0.00

estimate

0.41

3504

25958

(3002173) Hemoglobin [Mass/volume] in Arterial blood

4064

21784

1.90

283.74

9.9

8.2

124.76

121.58

g/l

17.08

3987

21163

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

10898

76127

1.55

281.96

2.3

2.1

193.64

201.27

u/l

0.37

10246

71657

(3021601) Nitrite [Presence] in Urine by Test strip

17864

138390

1.49

281.57

5.7

4.5

0.00

estimate

0.49

3768

26532

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1331

4464

2.95

277.19

3.6

3.1

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

3874

20667

1.90

273.83

8.8

7.1

1.43

1.33

mmol/l

6.05

3773

20193

(3015736) pH of Urine

14891

111700

1.49

271.87

3.8

3.1

5.73

5.90

8.44

1006

10090

(3044889) 12 lead EKG panel

22920

187627

1.50

268.84

4.2

3.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2335

10433

2.24

267.14

4.1

3.3

25.42

25.21

mmol/l

1.95

2276

10103

(4146454) Self-monitoring of blood glucose

832

2148

3.80

263.54

2.7

2.8

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2192

9609

2.28

262.42

5.0

3.7

50.15

48.81

1.62

2164

9511

(3021589) Normoblasts [#/volume] in Blood

16195

124113

1.47

262.04

11.2

8.9

0.00

e9/l

3.13

13330

102126

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

797

2006

3.89

261.72

1.4

1.3

1.71

1.35

nmol/l

12.49

736

1800

(3004119) Hemoglobin [Mass/volume] in Venous blood

2795

13567

2.07

258.33

4.1

3.3

130.50

129.64

g/l

1.13

2729

13254

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

5975

36925

1.67

253.86

1.9

1.7

1.44

1.42

2.72

5236

32892

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2533

11994

2.11

249.77

10.8

9.7

24.67

24.23

mmol/l

8.25

2441

11652

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1199

4044

2.92

246.87

1.1

43.84

2988.40

iu/ml

0.67

272

942

(3000850) Epithelial cells [#/volume] in Urine

8074

54042

1.57

246.27

2.9

2.5

7.57

6.00

e6/l

15.63

7251

48220

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

282

269

10.17

245.95

1.0

1.1

71.23

91.12

ug/l

8.14

250

211

(36304419) Bacteria [Presence] in Urine

10032

70747

1.51

239.61

3.4

2.9

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1399

5204

2.65

239.06

3.3

3.1

8.26

8.52

kpa

6.45

1374

5077

(3021901) Oxygen saturation in Capillary blood

1166

3956

2.90

237.43

3.2

2.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5036

30266

1.70

235.97

2.7

7.75

8.02

umol/l

0.38

4245

26128

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

33464

303265

2.18

234.90

13.2

9.5

30.63

25.92

u/l

211.73

32703

293658

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4459

26028

1.74

231.87

1.9

1.7

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

33288

301364

2.09

229.36

21.8

13.8

77.89

73.80

umol/l

51.32

33279

301249

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4467

26203

1.73

227.97

1.9

1.7

—

(3037522) Nuclear Ab [Titer] in Serum

6239

40172

1.60

221.42

1.4

477.54

553.41

titre

2.55

1155

8178

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3305

18001

1.85

216.05

3.0

2.7

163.71

172.65

ng/l

0.69

2919

16341

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

5018

30838

1.66

214.20

5.2

4.1

29.71

32.55

71.90

3956

21817

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2799

14507

1.93

213.17

10.9

9.3

1.47

1.37

4.30

2776

14421

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2795

14488

1.93

212.77

11.0

9.4

0.65

0.68

5.31

2774

14409

(3014007) Fractional oxyhemoglobin in Arterial blood

2799

14575

1.92

210.08

11.1

9.5

93.01

94.18

19.39

2787

14523

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2178

10484

2.07

204.30

3.6

2.9

1.44

1.29

6.30

2166

10430

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2141

10241

2.08

204.27

3.6

2.9

0.66

0.65

0.14

2131

10202

(3027945) Reticulocytes/100 erythrocytes in Blood

4291

25678

1.69

201.71

2.5

2.6

1.98

1.73

37.35

3772

22913

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2689

14217

1.89

191.99

8.5

7.1

25.07

24.49

mmol/l

10.87

2585

13498

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3178

17783

1.79

188.83

1.7

1.6

—

(1616796) Gas panel - Central venous blood

1306

5264

2.44

188.19

4.8

3.3

—

(40758558) Short blood count panel - Blood

9553

69309

1.45

187.97

6.6

6.9

—

(3019225) pH of Specimen

4001

23922

1.69

187.73

4.5

4.0

—

(4200892) Spirometry reversibility

3301

18770

1.77

185.51

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

513

1203

4.15

185.47

2.0

1.5

1.62

1.13

nmol/l

12.66

394

956

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

2263

11425

1.97

185.25

5.1

4.5

24.20

24.11

mmol/l

0.59

2209

11205

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2750

14840

1.85

183.81

8.4

7.1

25.17

24.70

mmol/l

7.26

2723

14720

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1817

8569

2.10

179.45

2.2

2.0

1.90

2.10

ug/l

0.40

1612

7592

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2511

13357

1.87

175.32

1.8

1.6

—

(3034770) Mitochondria Ab [Titer] in Serum

1624

7414

2.16

174.37

1.2

1.3

996.00

939.65

titre

0.11

228

(40761511) CBC panel - Blood by Automated count

32934

300171

1.83

174.23

18.5

11.4

—

(3020891) Body temperature

1866

9028

2.05

171.87

5.7

4.9

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6436

43865

1.51

171.45

2.9

2.6

1.37

1.12

e6/l

2.30

3651

24544

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2649

14437

1.83

171.02

1.6

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6559

44943

1.50

170.06

2.7

3.0

2.45

2.44

mmol/l

3.60

5608

39452

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13729

107463

1.38

169.96

4.5

3.4

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

6836

47361

1.48

167.48

4.1

3.4

331.09

519.43

ng/l

2.90

4934

33414

(3007164) IgA [Mass/volume] in Serum or Plasma

8068

57735

1.45

167.16

1.5

1.4

2.57

2.29

g/l

27.37

4929

35968

(3020630) Protein [Mass/volume] in Serum or Plasma

3208

18655

1.72

165.53

2.0

2.6

66.82

66.68

g/l

0.47

2921

17122

(3007566) Smooth muscle Ab [Titer] in Serum

1621

7545

2.12

165.44

1.2

1.3

119.14

123.66

titre

0.08

151

704

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1570

7222

2.14

165.18

3.3

0.34

0.35

u/ml

0.26

907

4080

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

6908

48170

1.47

163.23

1.3

9.23

11.28

u/ml

1.88

2662

19373

(3000494) Fungus identified in Specimen by Culture

4869

31566

1.56

162.48

1.5

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6017

40895

1.50

161.24

3.0

2.8

5.06

2.97

e6/l

8.45

3254

21725

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

7229

51033

1.46

159.79

1.3

31.35

33.19

iu/ml

0.25

2075

16534

(3029937) Albumin [Presence] in Urine by Test strip

9876

73923

1.40

157.07

4.7

3.7

0.01

0.00

estimate

0.75

3562

25742

(3028026) IgM [Mass/volume] in Serum or Plasma

2791

15844

1.76

156.48

1.6

1.9

1.16

1.34

g/l

9.45

2544

14541

(3018405) Lactate [Moles/volume] in Arterial blood

1644

7853

2.07

156.48

4.7

4.2

1.42

1.36

mmol/l

1.21

1612

7714

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

9071

67216

1.40

152.05

1.3

1.51

1.62

u/ml

0.38

2458

18722

(44816559) Phosphatidylethanol [Mass/volume] in Blood

1236

5347

2.27

151.19

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

5484

37101

1.50

148.96

1.7

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

7612

54863

1.43

148.83

1.8

1.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

3171

18904

1.68

148.35

3.1

3.4

4.48

4.52

pmol/l

1.48

2781

17007

(3009214) Lutropin [Units/volume] in Serum or Plasma

1866

9497

1.94

148.31

1.4

1.3

8.67

10.42

u/l

8.85

1522

7803

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4272

27592

1.56

143.44

3.5

4.4

236.05

239.90

u/l

0.98

4025

26224

(3005719) IgG [Mass/volume] in Serum or Plasma

3382

20742

1.63

141.20

2.3

2.7

10.60

10.50

g/l

0.72

3087

19046

(3008037) Lactate [Moles/volume] in Venous blood

1067

4494

2.33

138.87

3.9

2.8

1.64

1.54

mmol/l

2.72

1048

4392

(3023520) Reticulocytes [#/volume] in Blood

3113

18808

1.65

137.78

2.6

80.61

69.13

e9/l

43.06

2328

14065

(3013139) Helicobacter pylori Ag [Presence] in Stool

3112

18826

1.65

137.01

1.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3882

24820

1.57

135.77

2.6

2.5

51.77

44.12

u/l

0.24

3221

21375

(3010421) pH of Blood

1349

6325

2.10

134.64

5.6

3.5

7.41

7.42

5.02

1231

5786

(3027315) Oxygen [Partial pressure] in Blood

1212

5483

2.17

132.66

5.6

3.6

8.57

8.80

kpa

4.79

1185

5366

(3013290) Carbon dioxide [Partial pressure] in Blood

1205

5451

2.17

131.91

5.6

3.6

5.20

4.96

kpa

18.15

1178

5335

(3012501) Base excess in Blood by calculation

1204

5450

2.17

131.58

5.6

3.6

3.03

2.35

mmol/l

9.30

837

3589

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

974

4054

2.35

130.21

1.7

1.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

8532

64012

1.37

128.51

4.1

3.4

—

(3038515) Glucose [Moles/volume] in Venous blood

997

4217

2.31

128.43

4.1

2.9

7.87

7.41

mmol/l

4.54

981

4134

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

2078

11470

1.79

127.37

2.0

1.6

5.17

3.61

mg/l

6.90

1946

7900

(3021387) Prolactin [Units/volume] in Serum or Plasma

2261

12793

1.75

127.27

1.7

1.6

305.92

311.52

mu/l

0.31

2022

11519

(3004588) Protein electrophoresis panel - Serum or Plasma

2576

15147

1.69

126.04

1.8

2.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

5511

38521

1.45

124.33

2.2

30.20

29.61

8.98

5344

37386

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1766

9342

1.86

124.27

5.8

4.9

1.79

1.69

2.29

1684

8709

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1180

5425

2.13

123.87

2.6

2.1

131.58

130.96

g/l

0.35

883

3922

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2008

11063

1.79

123.76

1.4

1.6

11.67

13.13

u/ml

0.24

302

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3866

25201

1.54

123.14

4.0

3.1

—

(3037121) Protein [Mass/volume] in Urine

1626

8418

1.90

122.29

3.0

3.3

0.38

0.31

g/l

1.76

769

3730

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3217

20184

1.59

121.22

4.9

3.7

1.22

1.23

mmol/l

17.24

2859

17620

(3043409) Potassium [Moles/volume] in Arterial blood

1382

6797

2.00

120.84

5.1

4.5

3.90

3.86

mmol/l

2.44

1368

6742

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1327

6436

2.02

120.67

1.3

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

425

1202

3.43

117.39

1.7

1.6

2.88

9.77

nmol/l

0.81

349

997

(40767503) Oxygen content in Capillary blood by calculation

1096

5017

2.14

116.28

3.3

2.4

16.55

16.64

0.29

661

2509

(3007930) Methemoglobin/Hemoglobin.total in Blood

1716

9184

1.84

116.19

6.0

5.0

0.85

0.91

8.56

1639

8570

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

529

1724

2.99

115.51

1.3

5.57

5.15

umol/l

1.49

489

1593

(3010015) Selenium [Moles/volume] in Serum or Plasma

147

165

8.61

113.65

2.2

1.7

1.32

1.33

umol/l

0.22

141

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1877

10392

1.78

113.54

1.8

1.67

1.47

g/l

15.57

1608

8966

(3019150) Specific gravity of Urine by Refractometry

7917

59670

1.36

113.26

4.6

3.6

1.02

kg/l

0.10

1186

8994

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

8133

61816

1.35

109.45

1.8

1.6

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2193

12826

1.69

108.94

12.4

9.6

—

(3011985) Renin [Units/volume] in Plasma

835

3523

2.31

108.10

1.5

1.6

78.44

63.51

mu/l

1.20

742

3159

(3020876) Protein [Mass/time] in 24 hour Urine

655

2477

2.58

107.73

2.6

1.68

1.26

g/24h

3.16

353

1259

(3041096) Erythrocytes [Presence] in Urine by Automated

9844

77181

1.32

106.22

3.9

3.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1068

5028

2.08

105.19

3.4

2.8

36.45

33.77

umol/l

2.79

986

4579

(3027456) Digoxin [Moles/volume] in Serum or Plasma

780

3234

2.35

105.12

3.1

3.0

0.81

nmol/l

0.16

613

2437

(1761482) Bacteria [#/volume] in Urine by Culture

1151

5598

2.01

103.69

4.4

3.7

—

(3017181) Myelocytes/100 leukocytes in Blood

3410

22404

1.52

103.55

4.3

4.1

0.85

0.96

1.60

1212

7174

(3021440) Promyelocytes/100 leukocytes in Blood

3271

21339

1.53

102.65

4.3

4.2

0.09

0.12

2.61

1076

6139

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1611

8778

1.80

102.62

1.6

144.76

314.94

titre

2.79

348

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1817

10255

1.74

102.59

2.0

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2987

19188

1.55

100.52

2.4

2.2

6.29

7.69

ug/l

2.70

2524

16933

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1852

10670

1.71

96.98

1.5

1.7

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1435

7694

1.83

96.29

1.9

1.7

32.64

43.72

nmol/l

47.86

1387

7516

(3033705) Calcium.ionized [Moles/volume] in Venous blood

614

2384

2.51

95.59

2.8

2.2

—

(3035285) Chloride [Moles/volume] in Venous blood

622

2433

2.49

95.32

2.8

2.2

105.78

105.70

mmol/l

0.15

617

2412

(3041354) Potassium [Moles/volume] in Venous blood

622

2434

2.49

95.24

2.8

2.2

4.06

4.03

mmol/l

0.94

617

2413

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1096

5409

1.98

94.67

1.4

1.3

17.27

26.96

u/l

28.57

893

4476

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1657

9317

1.75

94.65

1.9

1.8

—

(3028717) Thiamine [Mass/volume] in Blood

147

205

6.93

94.59

1.3

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

27873

251279

1.32

94.09

22.2

14.5

15.45

14.89

11.83

27594

246984

(3002179) Metamyelocytes/100 leukocytes in Blood

3120

20512

1.51

93.95

3.9

4.0

0.59

0.69

2.18

1063

6230

(3005322) IgE [Units/volume] in Serum or Plasma

2969

19319

1.52

93.87

1.3

265.96

227.93

u/ml

0.73

2771

17905

(3004775) Volume in Urine collected for unspecified duration

487

1710

2.77

92.79

2.3

739.35

659.70

2.71

332

1210

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

2541

16027

1.57

92.44

2.5

2.2

5796.88

6162.65

u/l

0.25

972

6538

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

753

3265

2.25

91.36

1.3

1.4

453.46

373.53

pmol/l

0.25

673

2849

(3024666) Lithium [Moles/volume] in Serum or Plasma

484

1722

2.73

89.93

13.5

11.8

0.61

0.62

mmol/l

0.52

443

1584

(3025159) Blasts/100 leukocytes in Blood

3081

20401

1.50

89.39

4.4

4.2

0.09

0.33

3.40

893

5254

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2883

18885

1.51

88.06

2.8

2.1

8.69

12.32

nmol/l

121.20

2544

17102

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1312

7049

1.82

87.35

1.4

1.5

14.65

14.28

iu/ml

0.03

163

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

992

4891

1.98

85.88

1.2

101.25

140.93

titre

0.37

108

(46235355) HIV 1 and 2 tests - Meaningful Use set

8392

65955

1.30

84.98

2.0

1.9

—

(3001186) Copper [Moles/volume] in Serum or Plasma

244

590

4.00

84.82

1.8

1.2

17.54

16.83

umol/l

1.30

221

520

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1470

8242

1.75

84.66

2.4

2.3

603.45

508.80

ug/l

0.23

1377

7643

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1226

6523

1.84

84.22

2.2

3.5

2.37

3.75

ratio

0.53

520

(3024928) Oxygen saturation in Venous blood

994

4940

1.97

84.10

4.1

3.4

—

(40761535) Cells panel - Urine sediment

3069

20548

1.48

84.02

3.9

3.3

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

569

2267

2.44

83.83

1.9

2.2

18.63

19.33

nmol/l

1.01

529

2163

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

211

461

4.43

83.81

1.5

1.4

5.75

5.60

nmol/l

0.20

200

440

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1253

6724

1.82

83.71

2.2

3.5

38.84

41.12

mg/l

0.35

957

5465

(3034860) Kappa light chains.free [Mass/volume] in Serum

1253

6733

1.82

83.34

2.2

3.5

54.36

57.76

mg/l

0.15

964

5469

(3000492) Spirometry study

4052

28635

1.41

82.90

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1913

11577

1.63

82.57

2.1

2.0

38.74

39.46

u/l

0.82

1696

10424

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

646

2748

2.29

82.04

1.1

—

(3000330) Specific gravity of Urine by Test strip

1989

12209

1.60

80.94

3.8

3.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

1031

5257

1.92

80.84

2.1

1.8

151.56

193.59

pmol/l

29.99

955

5016

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1317

7263

1.78

80.28

2.0

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

621

2623

2.30

80.20

11.0

7.5

8.23

7.11

mmol/l

2.80

514

2138

(3003694) ABO and Rh group [Type] in Blood

10560

86158

1.26

77.25

1.6

1.5

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

4311

31125

1.38

77.24

7.9

6.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1189

6436

1.81

77.15

1.5

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

3239

22267

1.44

76.91

1.2

133.48

145.94

iu/ml

0.96

1165

8610

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

758

3535

2.09

76.50

1.2

1.3

34.49

34.09

u/l

0.02

649

3100

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

682

3055

2.17

76.38

7.2

6.3

11.19

11.35

mg/l

0.41

626

2818

(3025941) Bacteria identified in Stool by Culture

2553

16871

1.49

74.19

1.3

1.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2065

13065

1.55

73.56

2.9

2.6

0.42

0.25

e6/l

3.38

2017

12646

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1307

7432

1.72

71.45

1.4

283.95

279.07

ug/g

0.35

727

4225

(3035637) Corticotropin [Mass/volume] in Plasma

714

3353

2.07

70.74

1.6

1.5

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

764

3691

2.02

70.04

1.2

1.3

0.19

0.25

nmol/l

0.41

230

(3048689) Calprotectin [Mass/mass] in Stool

5018

37603

1.33

69.97

2.3

2.4

139.37

124.37

ug/g

2.26

3991

29645

(3028271) Lactate [Moles/volume] in Capillary blood

776

3800

1.99

68.48

2.4

1.8

1.75

1.72

mmol/l

0.31

759

3707

(3000475) Leukocytes [#/volume] in Synovial fluid

1080

5890

1.79

68.29

1.7

1.6

13952.87

12721.79

e6/l

0.35

758

4321

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

760

3717

1.99

67.31

1.2

1.3

1.11

1.29

nmol/l

0.10

732

3577

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

702

3339

2.05

67.20

1.2

1.3

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

744

3620

2.00

66.87

1.1

1.50

g/l

0.08

658

3304

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

953

5036

1.85

66.84

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

952

5034

1.84

66.63

1.4

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

1049

5725

1.79

66.16

2.4

2.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

873

4503

1.89

66.06

1.9

1.6

—

(3016750) Collection duration of Urine

361

1297

2.70

65.93

2.1

2.2

496.54

500.71

min

0.32

260

1000

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1224

6989

1.71

65.86

3.5

3.8

1.83

1.42

mg/l

36.51

1118

6502

(3052851) Hemolysis interference index of Serum or Plasma

1318

7733

1.67

64.03

3.1

2.9

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1455

8755

1.63

63.99

1.5

1.8

0.26

0.23

g/l

43.94

1383

8310

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1432

8583

1.63

63.97

1.8

2.3

7.81

7.26

g/l

26.10

1296

7793

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1429

8562

1.63

63.93

1.8

2.3

4.02

3.65

g/l

18.23

1296

7778

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1430

8571

1.63

63.88

1.8

2.3

—

(3017569) Oxygen content in Arterial blood

285

933

2.96

61.94

2.1

2.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

940

5070

1.81

61.67

2.2

3.6

—

(3017732) Neutrophils [#/volume] in Blood

2824

19684

1.42

61.43

3.0

2.6

5.15

4.72

e9/l

1.05

2268

16307

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1478

9048

1.60

60.50

1.5

1.8

1.33

1.15

g/l

92.21

1412

8614

(3023323) Follitropin [Units/volume] in Serum or Plasma

2613

18019

1.43

60.32

1.4

1.3

20.56

27.82

iu/l

35.72

2186

15633

(3009466) Valproate [Moles/volume] in Serum or Plasma

754

3822

1.92

60.17

6.2

5.1

359.37

374.32

umol/l

2.00

669

3312

(21494755) Public health laboratory ask at order entry panel

2676

35201

0.71

60.06

1.4

1.3

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

301

1034

2.82

59.94

2.0

2.1

184.87

82.56

ug/min

0.62

224

(3003129) Base excess in Capillary blood by calculation

194

511

3.67

59.90

1.6

1.7

0.81

0.57

mmol/l

0.35

186

476

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

422

1713

2.39

59.78

12.9

13.0

839.93

837.48

nmol/l

0.03

405

1660

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

437

1804

2.35

59.60

18.7

18.0

3142.80

1965.69

nmol/l

0.30

421

1732

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

22904

205400

1.21

59.45

3.6

3.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1332

8002

1.63

58.91

1.7

2.3

10.08

10.13

g/l

0.17

1190

7172

(3009542) Hematocrit [Volume Fraction] of Blood

34063

321034

1.60

58.40

29.2

18.1

40.41

40.49

0.62

32608

303164

(3021788) Differential panel - Synovial fluid

850

4535

1.83

57.79

1.6

1.5

—

(3007461) Platelets [#/volume] in Blood

34081

321379

1.59

56.56

29.0

18.0

263.74

255.70

e9/l

96.22

33543

313814

(3022145) Colonoscopy Study observation

4104

30767

1.32

55.95

1.3

—

(3022806) Fractional oxyhemoglobin in Capillary blood

637

3129

1.98

55.76

2.3

1.7

89.27

90.27

4.16

625

3081

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1530

9639

1.55

55.25

2.0

1.7

—

(3035941) MCH [Entitic mass]

34087

321615

1.58

54.31

28.8

17.9

29.77

30.26

307.65

33805

317802

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

463

2044

2.20

53.88

1.1

295.13

433.21

mg/l

0.48

392

1866

(3020717) Zinc [Moles/volume] in Serum or Plasma

351

1376

2.47

53.72

1.7

1.4

16.32

27.40

umol/l

14.44

339

1304

(3024731) MCV [Entitic volume]

34087

321660

1.58

53.71

28.9

17.9

90.05

90.69

117.75

33806

317831

(3026361) Erythrocytes [#/volume] in Blood

34088

321686

1.58

53.52

29.0

18.0

4.57

4.51

e12/l

116.27

33484

313356

(3010813) Leukocytes [#/volume] in Blood

34090

321717

1.58

53.42

29.0

18.0

7.43

6.63

e9/l

307.65

33471

313325

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1225

7384

1.62

53.41

2.2

2.1

11.07

10.63

mg/l

1.16

1137

6920

(3044941) Cell count panel - Synovial fluid

721

3759

1.87

52.80

1.5

1.4

—

(3000963) Hemoglobin [Mass/volume] in Blood

34093

321802

1.57

52.75

29.2

18.1

135.15

135.64

g/l

8.05

33827

318016

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

313

1178

2.57

52.20

2.1

2.2

154.33

144.51

umol/l

0.17

163

583

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

596

2940

1.97

51.57

1.4

9.23

7.78

mmol/l

11.68

571

2847

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1316

8141

1.58

51.45

1.8

2.3

3.02

2.90

g/l

4.13

1183

7354

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

598

2961

1.96

51.19

2.2

2.0

24.54

25.39

mg/l

0.13

189

783

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1004

5823

1.68

50.93

1.5

1.7

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2934

21216

1.36

50.70

3.0

2.5

65.12

69.82

ml/min/173m2

6.11

1373

7980

(40768441) Liver Pathology biopsy report

428

1880

2.21

50.47

1.4

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

994

5779

1.68

49.96

1.4

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

804

4421

1.77

49.44

1.6

1.3

7.40

6.89

mmol/l

5.76

713

3968

(3023511) Choriogonadotropin [Units/volume] in Urine

1299

8106

1.56

48.88

1.4

1.3

—

(3019977) pH of Arterial blood

309

1196

2.50

48.65

2.9

2.5

7.41

7.43

1.49

121

396

(3036489) Thrombin time

1624

10645

1.49

48.60

1.9

2.1

21.11

21.35

0.76

1371

9170

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1195

7357

1.58

47.67

1.9

2.4

0.49

0.79

g/l

4.19

1036

6383

(3010838) Calcium [Moles/time] in 24 hour Urine

851

4813

1.72

47.39

2.0

1.9

5.27

5.24

mmol/24h

0.10

760

4320

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1344

8530

1.54

46.86

2.5

2.7

4.01

3.54

g/l

22.71

1277

8130

(3012565) Volume of 24 hour Urine

318

1270

2.42

46.82

2.2

1915.04

2009.25

0.88

285

1150

(40761536) Microorganisms panel - Urine sediment

3268

24296

1.33

46.71

4.7

3.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

428

1953

2.12

45.88

1.1

1.3

—

31.25

u/ml

—

(3011288) Drugs identified in Urine by Screen method

1429

9232

1.51

45.85

2.5

3.0

—

(3020491) Glucose [Moles/volume] in Blood

438

2017

2.11

45.85

2.0

1.7

7.14

6.43

mmol/l

4.07

294

1538

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

729

3993

1.77

45.45

1.3

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

827

4703

1.71

45.15

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1095

6698

1.59

44.89

1.7

2.2

36.85

38.25

g/l

11.54

961

5896

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1077

6565

1.60

44.81

1.8

2.3

0.00

0.03

g/l

4.83

984

6023

(3000034) Microalbumin [Mass/volume] in Urine

457

2160

2.05

44.64

3.7

2.8

62.22

50.37

mg/l

0.47

345

1513

(3025468) Yersinia sp identified in Specimen by Organism specific culture

628

3326

1.83

43.80

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

629

3335

1.83

43.71

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

952

5669

1.63

43.59

1.5

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

628

3333

1.83

43.51

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

872

5091

1.67

43.15

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

630

3372

1.81

42.46

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

641

3451

1.80

42.38

1.4

—

(3004809) Band form neutrophils/100 leukocytes in Blood

703

3894

1.75

42.19

2.7

3.3

1.24

1.58

2.13

617

3510

(3021879) Hepatitis B virus core Ab [Presence] in Serum

3180

23887

1.31

41.97

1.4

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

993

6050

1.60

41.40

1.8

2.3

0.00

g/l

0.09

902

5524

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

584

3089

1.83

40.93

1.6

58.41

54.57

1.37

366

1967

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

470

2329

1.96

40.24

1.6

1.5

29.06

33.28

1.63

296

1449

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

622

3373

1.79

40.16

1.4

—

(40768804) Tissue Pathology biopsy report

13288

115941

1.17

39.78

2.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

974

5970

1.59

39.60

1.8

2.3

0.00

g/l

-0.00

894

5513

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

729

4161

1.70

39.31

1.5

1.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

714

4062

1.71

38.97

1.2

1.5

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1377

9130

1.47

38.83

2.0

2.3

93.80

92.95

0.69

1311

8752

(3022621) pH of Urine by Test strip

2411

17635

1.34

38.23

3.3

2.7

—

(4034850) Laboratory test

1307

8609

1.48

38.10

10.8

8.5

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1713

11877

1.41

37.90

1.3

1.2

0.45

0.96

u/ml

2.69

174

1006

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

790

4655

1.65

37.75

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

249

1004

2.40

36.03

2.2

2.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1267

8387

1.47

36.02

2.4

2.6

194.68

180.97

6.42

1202

7940

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

171

574

2.88

35.77

1.2

317.44

341.76

pmol/l

0.24

119

435

(3037756) Immunofixation for Serum or Plasma

762

4517

1.64

35.58

1.3

1.8

—

(36660697) Celiac disease serology panel - Serum

3134

24060

1.28

34.68

1.2

—

(3047181) Lactate [Moles/volume] in Blood

1182

7778

1.48

34.63

7.5

5.5

1.40

1.27

mmol/l

5.20

1070

6874

(3001556) Androgen free Index in Serum or Plasma

116

315

3.56

34.46

1.3

1.1

—

(3036603) Volume of Urine

358

1712

2.02

34.00

1.5

1.6

2046.26

1989.19

0.48

347

1672

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

632

3621

1.69

33.66

1.4

—

(3044927) Protein electrophoresis panel - Urine

406

2038

1.93

33.56

1.3

1.2

—

(3014271) Vancomycin [Susceptibility]

235

954

2.38

33.54

3.1

2.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

4947

40140

1.22

33.18

2.1

2.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1522

10581

1.40

33.12

2.0

2.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

230

932

2.39

32.97

2.4

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1467

10149

1.41

32.84

1.2

1.3

—

(40768443) Skin Pathology biopsy report

1658

11717

1.38

32.71

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

692

4098

1.64

32.47

1.3

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

757

4587

1.60

32.35

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

873

5469

1.55

32.31

4.6

3.1

24.24

26.10

mg/l

0.75

579

3347

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

506

2756

1.78

32.29

1.2

57.91

62.97

u/l

1.19

461

2469

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

153

512

2.89

32.24

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

717

4295

1.62

32.13

1.5

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

269

1180

2.20

32.04

1.5

1.4

434.68

695.43

mu/l

1.76

257

1124

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

619

3577

1.68

31.95

2.7

2.6

363.50

532.85

u/ml

0.18

613

3526

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

552

3101

1.73

31.63

1.4

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1338

9169

1.42

31.61

1.6

1.8

—

(3022689) Creatine [Moles/volume] in Urine

186

697

2.58

31.54

1.5

1.4

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1803

12992

1.35

31.45

2.4

2.3

—

(3004451) EKG impression Narrative

242

1028

2.28

31.16

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1688

12063

1.37

31.05

1.1

1.47

11.70

u/ml

2.02

180

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

271

1212

2.16

30.78

1.5

1.4

72.74

72.87

0.05

259

1156

(3014765) Yersinia sp identified in Stool by Organism specific culture

1231

8355

1.43

30.67

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

5414

44647

1.20

30.35

2.2

2.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

681

4086

1.62

30.34

1.5

1.7

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1219

8276

1.43

30.33

1.2

—

(3002256) Pathology report gross observation

4461

36133

1.22

30.20

1.2

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

680

4085

1.62

30.15

1.5

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

1229

8373

1.43

30.00

1.2

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

569

3273

1.69

29.91

1.5

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

429

2280

1.82

29.75

1.5

1.4

104477.64

98467.40

e6/l

0.07

314

1559

(3013005) Retinol [Moles/volume] in Serum or Plasma

266

1200

2.14

29.58

1.7

1.8

1.89

1.98

umol/l

1.17

252

1122

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

399

2078

1.86

29.53

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

399

2078

1.86

29.53

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

399

2078

1.86

29.53

1.4

1.7

—

(3023419) Bacteria identified in Sputum by Culture

597

3492

1.66

29.45

2.5

—

(3002079) Sodium [Moles/time] in 24 hour Urine

274

1257

2.11

29.18

1.2

179.23

152.77

mmol/24h

4.90

274

1257

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

749

4655

1.56

28.76

1.3

1.2

4.24

3.85

u/ml

0.34

311

2068

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

421

2249

1.81

28.73

1.2

145.24

180.34

titre

0.46

386

(3006270) Folate [Moles/volume] in Blood

391

2042

1.85

28.70

1.2

1.1

383.42

377.62

nmol/l

0.21

308

1814

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

317

1544

1.99

28.69

1.4

1.5

19.96

24.35

u/ml

0.96

289

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1425

10051

1.38

28.43

1.4

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

418

2244

1.80

28.08

1.2

210.91

158.31

titre

0.18

(3008898) HLA-B27 [Presence]

1569

11265

1.36

28.00

1.1

—

(37021550) Renin [Units/volume] in Plasma --upright

146

516

2.73

27.86

1.3

98.88

78.58

mu/l

0.39

107

395

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

764

4815

1.54

27.58

1.3

1.2

3.69

3.43

u/ml

0.13

234

1661

(3024980) IgG subclass 4 [Mass/volume] in Serum

730

4577

1.55

26.98

1.4

1.6

0.68

0.74

g/l

1.07

557

3477

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

302

1481

1.97

26.85

1.3

1.4

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

188

765

2.37

26.81

1.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

563

3334

1.64

26.51

1.5

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

297

1459

1.97

26.28

1.3

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

463

2611

1.72

26.26

2.7

3.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2586

30730

0.80

26.26

1.7

—

(3045424) Erythrocytes [Presence] in Urine

745

4723

1.53

26.19

1.5

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

708

4466

1.54

25.49

1.1

125.52

117.60

8.06

632

4045

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1122

7762

1.41

25.14

2.5

2.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1675

20889

0.76

25.11

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

242

1124

2.08

25.04

1.3

1.5

—

(3045414) Leukocytes [Presence] in Urine

1701

12564

1.32

25.03

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

242

1125

2.08

24.98

1.3

1.5

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1008

6853

1.43

24.92

1.2

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

261

1251

2.02

24.80

2.2

2.1

22.84

27.56

umol/l

0.26

112

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

338

1768

1.85

24.77

1.6

1.4

5.66

5.50

mmol/l

1.68

318

1680

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

923

6182

1.45

24.75

1.5

1.4

12.81

20.36

u/ml

2.13

117

(3000012) Reticulocyte production index

515

3044

1.64

24.47

2.1

2.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1262

8945

1.37

24.44

1.7

1.6

1.67

6.18

iu/ml

0.90

269

1791

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

924

6214

1.44

24.25

1.5

1.4

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

237

1114

2.06

23.78

1.7

1.8

28.42

29.23

umol/l

0.57

232

1068

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2123

16257

1.27

23.71

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2123

16275

1.27

23.49

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

407

2294

1.72

23.19

1.5

2.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

169

3.88

23.10

1.7

1.9

44.84

45.78

umol/l

0.09

169

(43055514) Macroprolactin [Presence] in Serum or Plasma

202

904

2.16

23.06

1.5

1.4

—

(3016879) Cocaine [Presence] in Urine

1703

12730

1.30

22.96

2.0

2.1

—

(3000764) Benzodiazepines [Presence] in Urine

1820

13730

1.29

22.88

2.0

—

(3039000) Anion gap in Blood

807

5351

1.46

22.84

8.8

6.5

11.39

11.17

mmol/l

1.03

739

4806

(3018572) Chloride [Moles/volume] in Blood

807

5352

1.46

22.82

8.8

6.6

105.15

105.27

mmol/l

0.33

739

4807

(3008116) Ketones [Moles/volume] in Urine by Test strip

134

506

2.56

22.53

1.3

1.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

411

2345

1.70

22.42

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

277

1405

1.91

22.40

1.1

6.76

10.40

u/ml

1.07

256

(3034274) Bile acid [Moles/volume] in Serum --fasting

785

5207

1.46

22.19

2.1

2.2

5.44

6.40

umol/l

1.42

572

3789

(3017315) Amylase [Enzymatic activity/volume] in Urine

281

1440

1.89

22.03

1.4

1.2

277.18

324.75

u/l

0.40

265

1341

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

335

1815

1.79

21.95

1.6

1.5

—

(4062490) Immunoglobulin typing, IgG

489

2936

1.61

21.87

1.4

—

(3027008) Opiates [Presence] in Urine

1821

13824

1.28

21.79

2.0

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

210

981

2.07

21.48

1.3

1.4

13.22

14.78

pmol/l

3.90

175

829

(3028300) Cannabinoids [Presence] in Urine

1822

13861

1.28

21.44

2.0

2.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

486

2930

1.61

21.39

1.4

2.83

2.99

g/l

1.11

345

2066

(3027135) IgG subclass 1 [Mass/volume] in Serum

486

2935

1.60

21.24

1.4

6.33

6.82

g/l

2.55

341

2069

(3024139) IgG subclass 3 [Mass/volume] in Serum

485

2931

1.60

21.14

1.4

0.40

g/l

0.06

344

2072

(1761868) Lipid panel - Serum or Plasma

12103

108052

1.12

21.09

3.4

2.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

847

5755

1.43

21.07

1.5

108.38

112.16

u/ml

0.56

204

1287

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

197

906

2.10

21.02

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

2082

16136

1.26

20.99

2.7

3.1

37.73

49.02

u/ml

2.06

1997

15602

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

102

348

2.83

20.94

14.4

9.4

5.49

5.31

mmol/l

0.25

102

348

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

905

6229

1.41

20.94

1.2

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

390

2241

1.68

20.76

3.2

2.8

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

358

2016

1.72

20.54

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

261

1343

1.88

20.25

1.2

1.3

73.33

75.59

titre

0.03

111

(3024891) Influenza virus A+B Ag [Presence] in Specimen

1054

7487

1.37

20.18

1.2

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

451

2714

1.61

20.03

1.6

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

164

716

2.21

19.99

2.3

1.8

6963.30

11681.90

e6/l

0.65

381

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

853

5860

1.41

19.97

1.3

277.77

264.74

u/ml

0.67

521

3865

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

375

2157

1.68

19.91

1.3

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

205

978

2.02

19.85

1.9

2.5

0.66

1.21

ug/l

6.29

187

931

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1454

10851

1.30

19.85

1.8

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1879

14488

1.26

19.79

1.6

1.4

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

287

1533

1.81

19.78

1.2

1.3

80.10

88.74

u/l

1.08

255

1338

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

265

1381

1.85

19.78

1.2

1.3

595.88

403.00

titre

0.26

(3026692) Albumin [Mass/volume] in Peritoneal fluid

137

557

2.37

19.73

1.5

1.4

13.26

13.32

g/l

0.02

111

412

(3051101) Glucose [Moles/volume] in Cord blood

339

2.79

19.64

6.1

5.4

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

124

489

2.45

19.12

1.3

1.6

—

(3032057) Clostridioides difficile [Presence] in Stool

122

478

2.46

19.07

2.0

1.8

—

(3049717) Cytology report of Urine Cyto stain

1146

8319

1.34

19.06

2.3

2.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

279

1497

1.80

18.97

1.2

1.3

20.92

22.87

u/l

0.38

240

1292

(3023487) Leukocytes [#/volume] in Peritoneal fluid

178

820

2.10

18.97

2.3

1.9

3297.58

3338.27

e6/l

0.00

120

558

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

156

683

2.21

18.92

3.6

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

156

683

2.21

18.92

3.6

2.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

307

1696

1.75

18.90

1.3

1.4

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

352

2024

1.68

18.75

1.1

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

405

2416

1.62

18.69

2.7

3.3

58.70

56.42

1.47

340

2072

(3002331) Protein [Mass/volume] in Peritoneal fluid

122

483

2.44

18.66

1.5

1.4

26.71

28.63

g/l

0.24

371

(3027944) Amphetamines [Presence] in Urine

1766

13612

1.26

18.65

1.9

2.0

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

236

1211

1.88

18.52

1.5

5.15

3.83

0.58

280

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

115

446

2.49

18.39

3.6

2.1

7.81

7.38

mmol/l

0.45

267

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

514

3255

1.53

18.32

1.2

1.1

98.30

94.58

2.35

483

3049

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

512

3245

1.53

18.18

1.8

1.6

8.51

7.52

mmol/l

17.86

479

3129

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1064

7694

1.34

18.18

1.3

4.90

9.26

u/ml

3.03

134

1232

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1144

8371

1.33

18.03

1.3

29.82

37.02

u/ml

0.30

524

(3033799) Differential panel - Peritoneal fluid

158

710

2.15

17.98

2.4

1.9

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

240

3.05

17.96

1.6

1.5

107.78

113.26

ug/l

0.16

201

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

5.93

17.95

4.9

5.6

0.23

0.25

mmol/l

0.14

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

876

6159

1.38

17.92

1.2

1.3

4.71

5.38

u/ml

0.12

478

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

305

1710

1.72

17.86

1.5

1.9

—

(3000093) Morphology [Interpretation] in Blood Narrative

385

2295

1.62

17.84

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1010

7275

1.35

17.72

1.4

126.52

118.76

pmol/l

0.24

975

7100

(3039443) Prostate specific Ag panel - Serum or Plasma

291

4715

0.59

17.64

1.6

—

(3035320) C reactive protein [Mass/volume] in Body fluid

341

1977

1.67

17.64

3.2

2.3

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

253

2.97

17.61

8.8

7.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

863

6072

1.38

17.59

1.2

12.95

14.88

u/ml

0.08

(3006576) Bicarbonate [Moles/volume] in Blood

173

816

2.05

17.36

6.9

6.2

25.76

24.91

mmol/l

1.47

157

747

(3019832) Treponema pallidum Ab [Presence] in Serum

4631

39321

1.15

17.23

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

304

1722

1.71

17.17

1.1

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

453

2832

1.55

17.16

1.5

1.6

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

402

2446

1.59

17.14

1.5

1.8

—

(3004616) Nuclear Ab [Presence] in Serum

540

3507

1.49

17.10

1.3

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

452

2833

1.54

16.93

1.5

1.6

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

158

731

2.09

16.72

1.5

1.4

54.26

52.05

0.30

138

625

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

886

6314

1.36

16.69

1.2

1.3

4.02

3.67

mmol/l

14.29

822

5933

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1038

7578

1.33

16.65

1.3

6.75

6.29

u/ml

0.07

800

(3035947) Staphylolysin Ab [Units/volume] in Serum

241

1289

1.81

16.64

1.2

1.1

3.71

3.64

iu/ml

0.04

(3019420) Tryptase [Mass/volume] in Serum or Plasma

288

1624

1.71

16.56

1.3

1.5

6.78

8.09

ug/l

1.30

260

1464

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

357

2132

1.62

16.47

1.4

1.6

—

(3042631) Mycobacterium sp identified in Specimen

480

3067

1.51

16.47

2.3

2.6

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

319

1854

1.66

16.39

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

320

1863

1.66

16.33

1.1

—

(40762365) Oxygen content in Arterial blood by calculation

363

2.55

16.25

3.3

2.8

14.89

14.90

ml/dl

0.01

338

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1097

8101

1.31

16.23

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

429

2690

1.54

16.07

1.4

1.7

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

508

3313

1.48

15.80

1.2

1.1

1.10

2.20

iu/ml

—

(3024263) Appearance of Synovial fluid

234

1270

1.78

15.43

1.4

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

331

1977

1.62

15.30

1.1

1.06

ratio

0.07

106

727

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

232

1272

1.76

14.80

1.4

2.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

284

1651

1.66

14.64

1.5

1.6

6.25

7.19

u/l

0.66

222

1328

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

976

7201

1.31

14.57

1.3

526.49

513.93

mg/l

0.15

928

6866

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

233

1287

1.75

14.50

1.9

2.3

22.26

169.82

ug/l

1.82

222

1226

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

243

1359

1.73

14.47

1.1

21.51

24.14

u/l

0.38

223

1231

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

299

1769

1.63

14.40

2.1

100.21

98.40

0.42

276

1635

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

242

1360

1.72

14.17

1.1

80.96

83.27

u/l

0.24

225

1232

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

230

1276

1.74

14.11

1.4

2.0

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

196

1038

1.82

14.07

1.0

—

(3051611) Lipemic interference index of Serum or Plasma

409

2622

1.51

13.90

3.4

3.2

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1017

7602

1.30

13.81

1.9

11.87

20.13

iu/l

0.33

362

2907

(3051593) INR in Capillary blood by Coagulation assay

181

944

1.85

13.66

12.9

8.8

—

(44813793) Dust mix specific IgE antibody measurement

355

2217

1.55

13.63

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

249

1429

1.68

13.53

1.6

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

348

2173

1.55

13.38

1.2

1.3

0.78

1.75

u/ml

2.24

187

1190

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1154

8805

1.27

13.34

1.4

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

479

3202

1.45

13.21

2.4

2.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

782

5678

1.33

13.12

5.0

6.0

7141.92

1257.52

iu/ml

0.44

848

(3038026) Centromere Ab [Units/volume] in Serum

357

2253

1.53

13.10

1.2

48.43

46.70

u/ml

—

105

(3003181) Sodium [Moles/volume] in Urine

560

3857

1.40

13.09

1.3

1.4

63.42

64.05

mmol/l

0.12

404

3055

(3020191) Ethanol [Moles/volume] in Serum or Plasma

365

2318

1.52

13.01

1.6

1.5

1.28

1.41

promille

1.00

279

1772

(3020961) Endomysium IgA Ab [Titer] in Serum

1854

14932

1.21

12.96

1.1

214.10

200.24

titre

0.05

376

(3003327) Ova and parasites identified in Stool by Light microscopy

1347

10502

1.24

12.93

1.7

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

314

1946

1.56

12.53

2.1

1.9

2.23

2.13

u/field

0.12

139

907

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

200

1105

1.75

12.51

1.1

1.2

0.32

0.30

g/l

2.84

160

870

(3036180) Methadone [Presence] in Urine

255

1505

1.64

12.48

1.9

2.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

346

2198

1.52

12.34

1.2

77.00

66.89

u/ml

0.20

107

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

242

1414

1.65

12.33

1.1

100.10

96.19

1.11

178

1137

(3027570) Oxalate [Moles/time] in 24 hour Urine

165

3.04

12.32

2.0

1.3

355.08

326.28

umol/24h

0.40

165

(3051651) Icteric interference index of Serum or Plasma

257

1525

1.63

12.32

3.8

3.7

—

(3044007) Cell count panel - Peritoneal fluid

134

657

1.97

12.24

2.4

1.8

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

610

4313

1.37

12.21

2.3

3.0

502.73

7431.20

u/ml

1.40

239

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

139

691

1.94

12.20

1.5

1.2

80.11

134.79

nmol/l

5.17

519

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

346

2204

1.52

12.19

1.2

68.71

42.29

u/ml

0.80

172

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

101

447

2.18

12.12

2.1

2.7

106.26

32.07

mg/l

1.37

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

187

1024

1.76

12.09

1.1

1.2

110.57

111.24

0.15

164

920

(3023420) DNA double strand Ab [Units/volume] in Serum

480

3272

1.42

11.95

1.5

1.6

31.61

34.61

iu/ml

0.21

163

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

221

2.71

11.92

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1451

11511

1.22

11.85

1.4

1.3

190.40

227.39

miu/ml

3.82

605

5587

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

267

1618

1.59

11.77

1.0

1.1

2.34

6.03

nmol/l

1.51

309

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

397

2.24

11.76

4.1

4.8

65.13

39.96

ug/min

1.94

300

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

110

510

2.08

11.74

3.0

2.4

—

(3042733) HLA Ab [Presence] in Serum

182

998

1.76

11.73

5.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

270

1646

1.58

11.61

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

331

2114

1.51

11.55

1.2

6.58

10.76

u/ml

0.53

162

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

197

1110

1.71

11.54

3.0

3.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1055

8110

1.26

11.51

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

2608

21852

1.16

11.44

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

113

535

2.04

11.42

1.2

15.65

58.17

mg/l

1.08

395

(3027035) Albumin [Mass/time] in 24 hour Urine

221

2.66

11.39

1.3

669.01

232.76

mg/24h

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

3.88

11.37

2.1

2.0

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

191

1072

1.72

11.36

3.0

2.8

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

285

2.44

11.22

3.0

2.5

1.16

1.17

mmol/l

0.01

200

(3026389) Candida sp identified in Specimen by Organism specific culture

606

4344

1.35

11.16

1.4

1.3

—

(3044290) Cell count panel - Cerebral spinal fluid

801

5974

1.30

11.15

1.3

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

173

952

1.75

11.04

2.6

2.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

1077

1.70

10.92

6.2

5.1

2068.02

3074.82

mg/l

0.28

134

797

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

846

6377

1.28

10.86

1.4

1.5

1031.40

2386.07

e6/l

1.06

688

5167

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

424

2.14

10.81

5.7

65.45

69.70

0.75

332

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

844

6372

1.28

10.71

1.3

1.4

62.36

22.81

e6/l

1.04

653

4910

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

2423

20296

1.16

10.67

2.4

2.3

22.06

22.68

au/ml

0.10

128

1769

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

2233

18607

1.17

10.53

1.3

36.17

50.21

au/ml

1.88

937

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

216

1281

1.63

10.47

1.6

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

924

7085

1.26

10.34

2.6

2.3

—

(40768800) Prostate Pathology biopsy report

301

4279

0.67

10.34

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

313

2027

1.49

10.28

1.3

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

311

2012

1.49

10.27

1.3

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

596

4334

1.33

10.02

1.2

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

176

1005

1.69

9.90

3.5

4.0

—

(3006462) Nitrate [Presence] in Urine

218

1318

1.60

9.80

3.5

2.8

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

215

1298

1.60

9.73

1.6

1.5

—

(40768446) Kidney Pathology biopsy report

189

1111

1.64

9.54

1.6

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

614

4518

1.31

9.52

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

176

1017

1.67

9.49

1.5

2.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

681

5089

1.29

9.42

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

267

2.35

9.41

1.1

1.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

403

2.08

9.41

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

873

6731

1.26

9.37

1.1

1.35

2.18

u/ml

3.26

483

3317

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1485

12087

1.19

9.33

1.4

1.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

329

2202

1.44

9.19

3.3

3.8

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

388

2.09

9.17

1.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

241

2.40

9.14

2.0

2.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

807

9705

0.80

9.09

1.5

1.4

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

754

5737

1.27

9.06

1.1

0.71

1.17

u/ml

1.68

332

2390

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

172

1001

1.66

9.05

1.5

2.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

829

6381

1.26

9.04

1.2

34.37

43.38

u/ml

0.81

634

(3043410) Blood group antigens tested for on Red Blood Cells

131

707

1.79

9.04

1.7

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

191

2.57

9.00

2.9

2.2

69.58

56.97

1.57

114

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1050

12261

0.82

8.95

1.5

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

788

6042

1.26

8.89

1.1

3.75

5.44

u/ml

3.55

426

3061

(4094501) Cardiovascular stress test using bicycle ergometer

916

7151

1.24

8.82

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

171

1001

1.65

8.81

1.5

2.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

831

9919

0.80

8.76

1.6

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

139

771

1.74

8.75

1.6

10.75

8.71

ug/l

4.54

139

771

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1336

10838

1.19

8.74

1.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

370

2556

1.40

8.69

1.4

1.6

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

160

925

1.67

8.66

1.1

2.42

6.41

u/ml

0.53

528

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

296

1969

1.45

8.58

1.1

7.47

8.51

iu/ml

0.42

516

(3005033) Fetal Nuchal fold Thickness US

811

9681

0.80

8.57

1.5

1.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1547

0.52

8.54

1.5

—

(3036670) Protein [Mass/volume] in Synovial fluid

126

687

1.77

8.43

1.3

1.2

36.97

40.21

g/l

1.63

361

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

441

1.97

8.40

1.1

1.0

0.29

0.35

u/ml

0.09

264

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

239

1542

1.50

8.12

1.2

28.93

10.47

u/ml

0.30

167

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

339

2341

1.40

8.02

1.8

1.7

—

(40768793) Breast Pathology biopsy report

548

6790

0.77

7.98

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

104

547

1.83

7.87

1.1

0.89

0.77

umol/24h

0.20

278

(3016018) Differential panel - Cerebral spinal fluid

433

3120

1.34

7.86

1.3

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

749

5800

1.25

7.82

1.5

1.4

0.40

0.43

nmol/l

0.42

602

4570

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

393

1.99

7.81

1.4

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

143

2.70

7.78

1.6

1.7

0.64

0.71

0.11

106

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

228

1472

1.50

7.74

1.1

—

(3008295) Osmolality of Serum or Plasma

348

2431

1.38

7.71

1.5

284.70

279.89

mosm/kgh2o

3.29

260

1915

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

5436

56305

0.92

7.64

3.8

4.0

22.49

21.74

2.41

2156

26116

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

150

2.63

7.64

2.9

2.3

13.67

16.88

0.35

(3001729) Color of Synovial fluid

173

2.51

7.59

1.6

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1096

8853

1.20

7.57

1.1

4.07

5.42

u/ml

0.73

126

1279

(3008402) Methanol [Moles/volume] in Serum or Plasma

284

2.14

7.41

1.1

1.3

—

0.96

mmol/l

—

(4281824) Cell count and differential, peritoneal fluid

413

2985

1.34

7.38

1.2

1.1

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

509

3789

1.30

7.37

1.3

1.2

38.81

53.00

u/ml

0.66

262

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

263

1766

1.44

7.33

2.7

3.3

100.89

129.92

nmol/l

1.39

258

1732

(3003434) Protein [Mass/volume] in Pleural fluid

374

2666

1.35

7.33

1.5

1.4

33.56

33.87

g/l

0.19

346

2415

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

154

2.57

7.27

1.2

134.65

108.02

ug/l

0.55

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

596

4536

1.27

7.25

1.1

—

(3002619) Bacteria identified in Specimen by Culture

101

541

1.80

7.25

1.3

1.2

—

(3024932) HLA-DR beta [Type]

160

973

1.59

7.17

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

219

1428

1.48

7.13

1.3

1.6

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

134

2.66

7.06

1.0

0.29

0.08

u/ml

0.69

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

397

1.92

6.93

1.1

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

218

1431

1.47

6.88

1.7

2.38

2.39

u/field

0.00

151

1038

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

177

1114

1.53

6.84

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3896

34499

1.10

6.80

1.5

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

366

4674

0.75

6.76

3.1

3.7

26.80

37.17

u/ml

1.28

348

4511

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

295

2.06

6.75

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

229

1525

1.45

6.72

1.1

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

259

2.12

6.61

1.0

1.2

39.01

45.93

mg/l

1.71

(3024471) HLA-A [Type]

161

1001

1.55

6.59

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

286

1990

1.39

6.57

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

102

2.83

6.46

1.1

1.4

590.68

484.56

nmol/l

0.43

102

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

225

1508

1.44

6.41

1.7

1.9

149.23

136.33

1.75

214

1420

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

104

584

1.72

6.40

1.4

1.6

0.43

0.38

ug/l

0.59

398

(3026470) Cobalt [Mass/volume] in Blood

198

1302

1.47

6.24

2.0

4.70

3.24

ug/l

1.30

178

1197

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

209

2.21

6.21

1.4

1.3

1.00

1.66

ml/s/173m2

0.83

139

(3016038) Potassium [Moles/volume] in Urine

219

1472

1.44

6.16

1.1

1.2

31.42

34.49

mmol/l

1.34

180

1276

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

167

1065

1.51

6.13

1.1

97.24

91.20

1.86

492

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

242

1658

1.41

6.12

1.6

1.4

6.28

5.84

u/l

0.28

211

1389

(3019897) Erythrocyte distribution width [Ratio] by Automated count

400

4971

0.77

6.08

3.4

2.4

13.47

13.12

8.23

395

4908

(3047189) Immunofixation for 24 hour Urine

160

1016

1.52

6.00

1.5

1.9

—

(40762814) Titanium [Mass/volume] in Blood

358

1.89

5.90

2.2

2.4

3.77

3.95

ug/l

0.09

127

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

491

1.75

5.87

1.2

1.4

0.21

0.28

nmol/l

1.01

355

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

309

2220

1.34

5.86

1.1

1.3

2.10

2.01

mmol/l

0.50

287

2070

(3018133) Calcium [Moles/volume] in Urine

423

1.80

5.77

2.0

1.9

2.92

2.58

mmol/l

0.67

383

(3023199) Leukocytes [#/volume] in Pleural fluid

333

2426

1.33

5.75

1.6

1.5

3221.36

3562.15

e6/l

0.10

248

1745

(3029634) Reagin Ab [Titer] in Serum by VDRL

561

4369

1.24

5.70

1.8

2.0

2.50

7.82

titre

—

103

(3025577) Chromium [Mass/volume] in Blood

191

1274

1.45

5.64

2.1

2.41

2.29

ug/l

0.15

151

1074

(3023410) Appearance of Cerebral spinal fluid

392

2935

1.29

5.56

1.4

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

158

2.32

5.51

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

257

1813

1.37

5.51

1.4

1.3

444.84

524.44

u/l

0.59

242

1727

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

157

1013

1.49

5.50

1.1

1.0

5.83

11.33

u/ml

4.28

591

(3035880) pH of Pleural fluid

164

1068

1.48

5.49

1.2

1.3

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.07

5.47

1.4

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

566

4440

1.23

5.40

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

104

614

1.63

5.38

7.7

8.9

—

(3042301) Urate [Moles/volume] in Synovial fluid

3.76

5.38

1.0

502.33

355.19

umol/l

—

(3028433) Virus identified in Specimen by Culture

143

910

1.52

5.36

1.2

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

469

1.73

5.35

1.5

1.4

25.35

23.91

0.17

392

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

106

631

1.62

5.31

1.3

36.72

40.62

0.42

432

(3023383) Lactate [Moles/volume] in Pleural fluid

100

589

1.64

5.23

1.4

1.3

3.58

3.54

mmol/l

0.04

541

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

121

2.47

5.17

1.0

0.14

0.06

u/ml

0.36

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

328

2427

1.30

5.12

1.3

—

(3017704) Immunofixation for Urine

180

1213

1.43

5.08

1.2

1.7

—

(3010375) cycloSPORINE [Mass/volume] in Blood

186

1266

1.42

4.98

28.1

28.3

116.58

118.87

ug/l

0.16

152

1051

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

494

1.68

4.98

1.0

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

164

1091

1.45

4.97

1.1

1.2

119.98

109.36

2.85

150

985

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

3044

27042

1.09

4.97

1.9

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

156

1029

1.46

4.95

2.8

2.4

144.70

152.63

nmol/l

0.50

138

900

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

391

2976

1.27

4.92

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

577

4584

1.22

4.91

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

104

630

1.59

4.89

1.3

1.2

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

180

2.14

4.86

1.5

1.2

23.78

21.35

mmol/l

1.76

134

(3001686) Cold agglutinin [Titer] in Serum or Plasma

447

1.70

4.84

1.2

1.4

21.71

174.30

titre

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

387

2949

1.27

4.83

3.0

3.3

5.20

7.77

nmol/l

0.68

358

2859

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

530

1.64

4.76

1.3

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

3.28

4.71

1.0

1.1

95.33

64.90

mu/l

0.26

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

113

705

1.55

4.70

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

169

1145

1.42

4.67

2.5

2.4

52.22

50.94

umol/l

0.18

141

995

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

345

1.79

4.66

2.5

2.6

75.07

59.69

pmol/l

0.38

293

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.59

4.63

1.0

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3978

40927

0.93

4.62

2.8

2.9

0.67

0.74

ug/l

3.71

2622

25966

(3000919) Neutrophils/100 leukocytes in Pleural fluid

520

1.63

4.60

1.3

1.4

27.50

22.06

0.93

476

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

156

1045

1.44

4.60

1.1

102.02

92.42

2.27

489

(21491868) Cryoglobulin [Mass/volume] in Serum

147

974

1.46

4.59

1.2

0.14

0.59

g/l

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

376

2877

1.26

4.56

1.0

1.1

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

484

3812

1.23

4.53

2.3

2.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

717

5862

1.18

4.50

1.7

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

278

2057

1.30

4.41

1.3

1.4

12.94

11.56

umol/l

2.41

254

1965

(3051339) Copper [Moles/volume] in Blood

145

2.19

4.29

1.3

17.67

16.50

umol/l

0.67

126

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

160

1093

1.41

4.27

2.3

2.7

159.33

151.37

au/ml

0.08

163

(3011436) Histone Ab [Units/volume] in Serum

584

1.57

4.26

1.1

—

36.88

u/ml

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

295

2214

1.29

4.23

1.6

1.5

75660.52

49736.11

e6/l

0.76

174

1316

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

2401

21266

1.09

4.22

1.8

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

167

1153

1.40

4.20

1.2

—

(3042517) Benzodiazepines panel - Urine

395

1.68

4.12

2.9

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

104

659

1.52

4.09

1.5

2.0

34.54

34.04

u/l

0.01

589

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.59

4.08

1.0

1.1

187.67

225.67

pmol/l

0.26

(3029612) Listeria sp Ab [Titer] in Serum

2.71

4.07

1.2

1.4

—

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

190

1349

1.36

4.04

2.0

2.1

200.39

198.55

u/l

0.16

190

1339

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

181

2.02

4.04

1.0

1.2

29.86

21.62

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

567

1.55

3.88

1.3

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

160

1115

1.38

3.85

1.8

1.9

174.62

156.45

1.22

152

1052

(3038071) Oxygen [Partial pressure] in Mixed venous blood

546

1.55

3.83

7.9

8.9

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

170

1198

1.37

3.82

2.7

3.2

7.73

8.12

mg/l

0.29

133

956

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

242

1800

1.30

3.77

1.8

1.7

—

(3026250) Tacrolimus [Mass/volume] in Blood

184

1319

1.35

3.72

36.2

36.3

7.34

7.38

ug/l

0.10

164

1203

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

318

2451

1.25

3.71

1.0

1.1

—

(3048879) Bone marrow aspiration report

100

643

1.50

3.71

1.3

2.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

690

5723

1.16

3.71

1.1

1.45

2.02

u/ml

1.20

381

2770

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.91

3.69

1.9

2.2

2.49

2.25

mu/l

0.09

(1175426) CD3 cells/100 lymphocytes in Blood

293

2242

1.26

3.65

1.7

2.1

73.94

73.40

0.27

287

2149

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

443

3544

1.21

3.63

1.2

—

(3036782) Glucose [Moles/volume] in Pleural fluid

261

1971

1.28

3.63

1.3

6.87

6.23

mmol/l

3.05

238

1822

(3011325) HIV 1+2 Ab [Presence] in Serum

144

2.07

3.56

1.1

1.0

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

336

2621

1.24

3.55

1.1

1.2

43.11

41.84

mg/l

0.18

290

2179

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.58

3.54

1.0

1.2

1524.80

4043.40

ng/l

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

113

2.22

3.52

1.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1018

8709

1.13

3.52

2.9

3.6

1093.17

2091.93

u/ml

0.50

851

7479

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.50

3.51

1.7

1.5

266.67

249.38

nmol/l

0.05

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

146

2.05

3.44

1.1

1.3

—

303.33

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

325

2537

1.24

3.42

1.0

1.1

237.93

257.43

mg/l

0.96

286

2223

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

195

1430

1.32

3.41

1.3

12.99

14.70

u/l

0.70

181

1323

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

132

912

1.40

3.39

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

169

2161

0.75

3.39

1.0

—

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.59

3.39

1.9

1.5

153.90

327.47

nmol/l

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

396

1.61

3.36

1.3

1.6

535853.53

189131.49

nmol/l

0.55

331

(3041918) Cholesterol [Moles/volume] in Pleural fluid

374

1.62

3.35

1.2

1.60

1.77

mmol/l

0.42

222

(3038177) Helicobacter pylori Ab [Presence] in Serum

625

5193

1.16

3.33

1.2

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

589

1.49

3.32

1.2

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

106

708

1.44

3.30

1.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

104

693

1.45

3.28

1.3

1.4

59.55

61.41

0.21

574

(3027874) Urate [Moles/volume] in Urine

2.47

3.28

1.1

1.14

1.76

mmol/l

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

584

1.49

3.25

1.3

1.4

1.52

2.94

1.85

494

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

202

1500

1.30

3.25

1.1

1635.96

1493.02

miu/ml

0.96

202

1500

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

106

711

1.44

3.23

1.1

—

(3011412) CD3 cells [#/volume] in Blood

356

2826

1.22

3.22

2.1

2.4

1.36

1.19

e9/l

3.35

322

2518

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5763

57961

0.95

3.22

1.5

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

652

1.45

3.13

1.1

1.24

3.74

u/ml

0.78

546

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

292

1.68

3.13

1.2

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

366

1.61

3.13

1.3

59.27

53.16

0.41

179

(3006969) Lambda light chains [Mass/volume] in Urine

2.81

3.07

1.1

1.0

0.02

0.09

g/l

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

355

2833

1.21

3.06

3.9

4.8

135.37

108.69

u/ml

0.29

108

921

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

356

2842

1.21

3.06

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

244

1.74

3.04

1.4

1.2

5.56

6.21

mmol/l

0.29

118

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

657

1.44

3.02

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

154

1116

1.33

2.98

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

204

1.80

2.93

1.0

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

240

1.73

2.92

1.2

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

450

1.52

2.91

1.1

1.4

74.82

296.08

ng/l

0.60

279

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

198

1.80

2.89

1.0

0.04

0.62

u/ml

2.25

181

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

397

1.55

2.89

1.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

119

1558

0.73

2.87

1.3

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

265

2069

1.24

2.86

2.2

2.6

545.27

512.45

e6/l

0.60

227

1730

(3002621) Streptococcal DNAse B [Units/volume] in Serum

249

1.70

2.85

1.0

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

149

1084

1.33

2.83

1.8

2.0

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

304

2412

1.22

2.82

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

304

2415

1.21

2.79

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

424

1.52

2.78

1.8

39.33

45.22

pmol/l

0.29

360

(3012441) Differential panel - Pleural fluid

268

2103

1.23

2.77

1.6

1.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

149

1088

1.32

2.77

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

172

1281

1.29

2.77

1.1

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

356

1.57

2.75

1.7

3.3

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

341

1.58

2.75

8.3

6.5

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

303

2410

1.21

2.75

1.2

—

(40757373) Influenza virus identified in Isolate

480

1.49

2.74

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

236

1830

1.24

2.73

1.5

—

(3045788) Cell count panel - Pleural fluid

242

1882

1.24

2.73

1.6

1.5

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

100

2.12

2.73

1.1

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

208

1590

1.26

2.73

1.2

1.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

165

1225

1.30

2.72

1.1

1.2

—

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

2.15

2.70

1.1

0.87

1.40

u/field

0.84

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

581

4889

1.15

2.68

2.8

3.5

679.64

834.76

u/ml

0.21

527

4440

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

263

2068

1.23

2.68

1.5

1.6

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

257

2017

1.23

2.67

2.2

2.6

0.24

0.23

e9/l

0.47

227

1735

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

305

2440

1.21

2.63

1.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

212

1.73

2.61

1.4

7.24

14.10

pmol/l

1.44

176

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

533

1.45

2.60

1.1

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

3.12

2.60

1.0

—

(3025130) Human papilloma virus identified in Specimen

478

5316

0.86

2.59

1.6

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

304

2435

1.20

2.59

1.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

178

1345

1.28

2.59

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

304

2437

1.20

2.57

1.2

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

2.37

2.57

10.4

8.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

184

1402

1.27

2.51

1.2

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1123

11846

0.91

2.50

1.4

—

(3000219) Insulin receptor Ab [Presence] in Serum

6.88

2.48

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1124

11852

0.91

2.48

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

469

1.46

2.44

1.4

1.3

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

188

1.74

2.43

1.1

0.39

1.33

u/ml

0.96

132

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

360

1.53

2.43

1.2

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1119

11787

0.91

2.42

1.4

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

133

977

1.31

2.42

2.4

3.0

30.37

28.37

umol/l

0.93

757

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

634

5409

1.13

2.42

1.6

1.5

—

(3035082) Kappa light chains [Mass/volume] in Urine

2.45

2.42

1.1

0.05

0.21

g/l

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

576

4886

1.14

2.41

1.1

18.29

10.54

au/ml

0.64

343

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1123

11822

0.91

2.40

1.4

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

119

1.94

2.40

1.1

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

228

1791

1.23

2.39

1.1

1.18

1.05

u/l

0.39

101

794

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.21

2.36

1.1

—

mmol/l

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

355

1.52

2.36

1.2

1.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2760

25159

1.06

2.35

3.3

4.1

26.95

23.72

ug/l

0.22

2185

19848

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

148

1108

1.29

2.35

1.9

2.0

7.05

9.55

mg/l

7.26

120

890

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

363

1.51

2.35

1.1

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

126

923

1.32

2.35

1.1

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

2.41

2.33

1.3

1.0

1.00

1.43

u/field

0.67

(3010503) CD19 cells [#/volume] in Blood

217

1702

1.23

2.32

2.4

2.6

0.19

0.28

e9/l

0.70

209

1661

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

7524

70292

1.04

2.32

4.4

4.6

2.16

2.83

ug/l

1.97

6645

63748

(3034426) Prothrombin time (PT)

143

1069

1.29

2.30

1.3

1.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

340

2787

1.18

2.28

1.8

2.0

25.95

24.12

ug/l

0.18

330

2726

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

137

1020

1.29

2.28

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.92

2.25

1.4

—

(3003157) Bacteria [#/volume] in Mother's milk

2.20

2.21

4.3

7.2

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

618

1.37

2.19

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

292

1.55

2.19

1.3

1.2

0.70

1.36

mmol/l

1.04

184

(40762887) Creatinine [Moles/volume] in Blood

2.51

2.18

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

285

1.56

2.17

1.0

1.2

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

3.75

2.17

1.0

1.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

159

1.76

2.16

1.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

538

1.40

2.16

1.4

1.3

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

152

1.77

2.16

1.0

1.2

1.10

1.24

u/field

0.37

101

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1108

11601

0.92

2.14

2.1

1.9

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

286

2325

1.19

2.14

1.5

1.3

23.20

32.55

nmol/l

8.96

248

2150

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

703

1.34

2.14

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

167

1.73

2.13

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

713

1.34

2.11

1.1

—

(40768806) Pleura Pathology biopsy report

261

2108

1.19

2.11

1.6

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.10

2.11

1.0

1.2

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

342

1.49

2.09

1.8

1.6

1.99

1.57

mg/l

0.97

283

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

296

1.53

2.07

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

430

1.43

2.07

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

111

1389

0.77

2.06

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

225

1802

1.20

2.01

2.0

1.6

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.16

1.99

1.0

1.4

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

713

1.32

1.97

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.21

1.97

11.7

8.1

45.11

46.67

—

(40765089) Chromosome analysis panel - Blood by G-banded

1062

0.74

1.96

1.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

100

732

1.32

1.94

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

278

1.53

1.94

1.2

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

412

1.43

1.93

6.3

7.0

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

115

1.84

1.93

1.5

0.00

0.04

u/l

0.49

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

534

1.37

1.93

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

240

1.57

1.92

1.3

22.68

25.96

0.26

185

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

257

2094

1.18

1.91

1.8

2.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

151

1.72

1.91

2.4

2.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

779

6830

1.10

1.90

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

539

4635

1.12

1.89

1.1

5.58

4.92

u/ml

0.21

231

1882

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

114

854

1.29

1.88

1.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

152

1.71

1.88

1.0

1.1

37.59

59.42

u/l

1.19

122

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

359

1.45

1.87

1.0

0.02

0.21

u/ml

2.55

215

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.31

1.86

1.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

235

1.56

1.85

1.0

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

118

892

1.28

1.82

2.8

3.2

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.00

1.78

1.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

222

1.56

1.78

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

292

1.48

1.77

1.1

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.95

1.77

1.0

—

(3019174) dRVVT (LA screen)

285

1.49

1.75

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

178

1.62

1.74

1.2

1.1

8.87

9.83

u/l

0.13

178

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

349

1.44

1.74

1.0

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

671

1.31

1.71

1.1

1.2

102.53

86.36

1.71

179

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

671

1.31

1.71

1.1

1.2

68.92

75.85

0.34

173

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1219

12582

0.93

1.71

1.5

—

(40758358) Immune stain study

121

1.75

1.68

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

296

1.46

1.68

1.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

441

3782

1.12

1.66

1.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

273

1.48

1.66

1.6

0.57

1.98

mg/l

4.17

175

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

219

1.54

1.65

1.2

14.54

15.92

nmol/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

115

883

1.26

1.60

1.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

164

1309

1.21

1.59

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

117

901

1.25

1.59

1.8

1.7

188.49

125.81

au/ml

0.68

105

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

364

1.40

1.59

1.0

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

316

1.43

1.58

2.8

3.4

37.16

42.63

umol/l

1.07

271

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

462

3990

1.12

1.57

1.1

1.0

0.25

0.41

u/ml

0.97

153

1005

(4212803) Bone marrow aspirate examination

192

1.56

1.54

1.2

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

326

1.42

1.54

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

172

1974

0.84

1.53

1.2

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

2.24

1.53

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

319

1.42

1.52

1.0

1.1

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

224

1.51

1.0

1.82

0.88

u/ml

0.21

143

(3003721) Smooth muscle Ab [Units/volume] in Serum

225

1.50

1.48

1.1

—

2.64

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

563

4930

1.10

1.48

1.1

5.02

4.32

u/ml

0.27

283

2283

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

724

1.26

1.44

1.3

1.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.34

1.44

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.12

1.44

1.0

1.1

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

1.84

2.44

mg/l

0.43

182

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

0.35

0.96

mg/l

2.01

177

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

0.79

2.12

mg/l

2.53

157

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

1.91

1.62

mg/l

0.21

188

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

1.07

2.33

mg/l

1.86

173

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

1.21

2.70

mg/l

1.46

184

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

0.81

1.18

mg/l

0.48

164

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

2.98

3.87

mg/l

0.40

168

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

267

1.44

1.42

1.6

2.56

2.02

mg/l

0.23

194

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

173

1.56

1.42

1.3

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.03

1.41

1.0

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

145

1161

1.20

1.40

1.6

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

145

1161

1.20

1.40

1.6

1.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

268

1.44

1.40

1.1

1.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

428

3709

1.11

1.40

1.7

4928.00

3322.11

titre

—

133

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

520

5503

0.91

1.39

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

182

1489

1.18

1.39

1.7

2.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

253

1.45

1.38

1.4

1.3

82.03

332.22

u/l

0.76

186

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

551

1.29

1.36

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

116

912

1.23

1.35

1.5

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

335

1.38

1.35

1.0

0.16

1.51

u/ml

0.64

176

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

170

1389

1.18

1.33

1.5

1.6

1897160.08

1816803.82

iu/ml

0.02

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

131

1.62

1.31

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

178

1.52

1.28

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

140

1.58

1.26

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

177

1460

1.17

1.25

1.3

57.60

65.99

0.50

173

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

247

2089

1.14

1.25

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

372

3225

1.11

1.25

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

267

1.41

1.24

1.6

1.5

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

156

1.54

1.24

1.3

1.7

185.53

178.50

ug/g

0.07

132

(3045683) HLA typing for celiac disease panel - Blood or Tissue

235

1981

1.14

1.24

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

118

940

1.21

1.24

1.8

1.7

4029.93

32049.70

u/ml

1.13

115

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.71

1.18

1.1

1.0

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

328

1.35

1.17

1.0

0.09

0.37

u/ml

0.85

183

(36303858) Crystals [Presence] in Urine

2.08

1.16

1.1

1.2

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

2.53

1.16

1.0

1.1

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

114

913

1.20

1.15

1.3

1.2

23.40

20.47

0.14

156

(3011897) Casein IgE Ab [Units/volume] in Serum

540

1.27

1.15

1.1

1.2

0.22

1.71

u/ml

1.15

533

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

543

1.26

1.11

1.4

1.2

328.87

315.38

ug/l

0.01

295

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

307

1.35

1.10

1.1

—

(3017509) Phencyclidine [Presence] in Urine

391

1.31

1.09

1.9

1.6

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

258

1.38

1.09

1.3

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

366

1.32

1.09

1.4

1.6

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

729

1.22

1.06

1.0

1.1

6.28

6.52

mg/g

0.21

691

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

101

1.62

1.05

1.1

1.3

0.75

1.18

u/field

1.30

(3017958) Strawberry IgE Ab [Units/volume] in Serum

101

1.62

1.05

1.0

0.01

0.06

u/ml

1.48

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

137

1128

1.17

1.04

1.1

468.45

624.89

ng/l

0.25

259

(3016031) Almond IgE Ab [Units/volume] in Serum

228

1.39

1.04

1.1

1.0

0.08

0.77

u/ml

3.36

125

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

212

1.41

1.03

1.0

—

(21494815) CD4 cells/100 lymphocytes in Specimen

289

2504

1.11

1.03

1.9

2.2

43.58

39.08

5.85

281

2462

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

481

1.26

1.02

2.4

4.9

52.33

68.21

u/l

0.68

472

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

2.04

1.02

1.0

1.2

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

232

1987

1.13

1.02

1.6

1.9

4.59

3.43

mg/l

2.85

218

1902

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

2.19

0.98

1.2

1.4

66.76

73.67

nmol/l

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.93

0.96

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.93

0.96

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.93

0.96

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.93

0.96

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.93

0.96

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.93

0.96

2.0

—

(40768795) Lymph node Pathology biopsy report

250

2679

0.90

0.95

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

211

1808

1.12

0.94

5.7

6.7

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

308

1.31

0.94

1.0

0.02

0.54

u/ml

2.46

178

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

679

1.21

0.93

2.6

85.01

106.07

ng/l

0.67

355

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

144

1.47

0.93

1.2

1.3

1.36

1.69

mg/l

0.69

120

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

160

1.45

0.93

1.1

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

0.50

0.93

1.0

—

(3000060) B lymphocytes [#/volume] in Blood

109

893

1.18

0.91

1.6

2.2

278.03

577.73

e6/l

0.52

484

(3006245) CD3-CD19+ cells/100 cells in Blood

143

1197

1.15

0.91

1.7

2.2

11.05

9.88

0.55

138

1108

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.14

0.91

1.5

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

472

1.25

0.91

1.1

—

(3049233) Organic acids panel - Urine

2.06

0.89

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

178

1.41

0.89

3.2

5.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2024

18830

1.04

0.89

1.7

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

228

1.35

0.87

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

295

1.31

0.87

1.3

13.10

13.73

0.05

154

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.78

0.87

2.4

2.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

139

1.46

0.85

3.1

3.4

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.57

0.85

1.1

256.07

247.17

nmol/l

0.06

(40758292) HTLV I+II Ab panel - Serum

485

0.77

0.85

1.1

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

205

1.36

0.84

1.2

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

197

1.37

0.83

1.0

1.1

16.80

15.76

iu/ml

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

323

1.28

0.83

1.0

4.96

1.39

u/ml

0.32

241

(3012989) Citrate [Moles/time] in 24 hour Urine

1.75

0.82

2.6

1.2

2.18

2.32

mmol/24h

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

111

0.52

0.82

1.3

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

1.65

0.82

1.0

142.50

399.60

u/l

1.27

(3024869) Neuronal Ab [Presence] in Serum

453

1.23

0.82

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

104

859

1.17

0.81

1.8

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

883

0.84

0.81

1.4

1.8

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

207

1.35

0.80

1.7

1.4

26.00

35.62

0.60

136

(3009992) Blasts/100 cells in Bone marrow

0.00

0.79

0.0

1.8

—

15.67

—

(3022475) Manganese [Moles/volume] in Blood

204

0.66

0.79

1.1

1.2

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

0.00

0.78

0.0

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

253

2671

0.91

0.77

3.6

3.8

44.78

44.56

u/ml

0.01

245

2651

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

571

1.20

0.77

1.1

0.40

3.39

u/ml

1.93

407

(3047185) IgG [Mass/volume] in Urine

1.66

0.76

1.1

1.0

—

45.20

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

218

1.33

0.75

1.1

19.87

23.04

u/l

0.54

145

(21494434) Karyotype in Bone marrow

227

1989

1.10

0.73

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

287

1.28

0.73

1.2

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

240

2109

1.10

0.73

1.1

0.63

2.91

u/ml

1.83

664

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

208

2208

0.91

0.72

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

178

1.35

0.71

1.0

1.1

—

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.73

0.70

1.0

0.10

0.13

u/ml

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

171

1.35

0.69

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.53

0.68

1.2

1.1

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

106

1.45

0.67

5.8

9.7

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

1.63

0.67

2.0

1.3

—

(3015183) Erythrocyte sedimentation rate

193

1687

1.10

0.67

1.3

1.2

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.57

0.64

2.1

4.5

—

(3010937) Rubella virus Ab [Presence] in Serum

216

1.29

0.63

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

526

5353

0.95

0.63

1.1

—

(3000285) Sodium [Moles/volume] in Blood

285

1.25

0.63

1.2

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

537

0.82

0.63

1.8

2.3

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

0.60

0.0

1.1

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

218

1.28

0.60

2.0

2.7

24.07

59.19

pmol/l

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3014891) Appearance of Pleural fluid

244

1.26

0.60

1.3

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.54

0.59

1.8

1.1

67.13

75.40

—

(3002523) Influenza virus A Ag [Presence] in Specimen

527

5349

0.95

0.59

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

491

0.82

0.59

2.8

3.2

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

490

0.83

0.58

5.7

6.3

—

(3007919) Fasciola sp Ab [Titer] in Serum

1.51

0.58

1.0

1.1

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

211

1.28

0.58

1.0

0.06

1.91

u/ml

1.67

162

(3006598) pH of Arterial cord blood

1.46

0.57

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

178

1.30

0.56

1.3

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

117

1009

1.12

0.55

1.0

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

205

1822

1.08

0.54

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

1.56

0.53

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

319

1.21

0.52

2.2

0.78

0.61

u/field

0.48

319

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.52

0.52

2.2

2.3

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

293

0.79

0.51

1.9

2.6

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

156

1642

0.91

0.51

2.4

2.7

44.05

39.65

2.50

106

905

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

138

1.33

0.51

1.1

1.2

—

14403.14

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

184

0.73

0.50

1.0

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

139

1.32

0.49

1.8

1.6

0.69

0.71

umol/l

0.07

105

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

235

2110

1.07

0.49

2.4

2.6

855.43

673.80

e6/l

5.47

225

2047

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

112

975

1.11

0.47

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

182

0.74

0.47

2.7

5.8

—

(3022725) Serotonin [Moles/volume] in Serum

1.38

0.47

1.2

1.4

676.07

964.35

nmol/l

0.63

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

149

1.29

0.47

1.1

1.7

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

124

1.32

0.46

1.2

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.62

0.45

1.0

1.1

—

(3013862) HLA-DP [Type]

113

0.68

0.45

1.0

—

(3007733) Chloride [Moles/volume] in Urine

1.46

0.45

1.1

1.5

78.70

90.04

mmol/l

—

(3018291) Platelet Ab [Presence] in Serum

1.40

0.45

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

370

1.17

0.45

1.1

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

299

1.19

0.44

1.2

1.4

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

460

1.15

0.44

1.1

1.4

—

(3046861) Legionella sp Ag [Presence] in Urine

125

1.31

0.44

1.2

1.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

230

2079

1.07

0.42

1.1

0.73

4.15

u/ml

1.42

488

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.64

0.42

1.0

—

(3041184) Isoniazid [Presence] in Urine

1.55

0.42

2.0

2.5

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

355

1.17

0.42

2.5

—

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

118

1.31

0.41

1.2

1.1

20.44

21.42

0.40

108

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

118

1.31

0.41

1.1

8.43

8.73

0.23

108

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

118

1.31

0.41

1.2

1.1

36.99

36.04

0.43

110

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.00

0.41

0.0

1.2

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

628

5833

1.04

0.40

1.3

3.61

3.58

ug/l

0.03

571

5274

(3009871) Measles virus Ab [Titer] in Serum

122

1080

1.09

0.39

1.7

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.39

0.0

1.6

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

(3022670) pH of Venous cord blood

1.31

0.39

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

171

1.24

0.39

1.0

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

385

1.15

0.38

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

175

0.77

0.38

6.2

4.9

—

(46235168) Fasting glucose [Moles/volume] in Blood

305

1.17

0.37

1.6

2.0

7.16

7.17

mmol/l

0.01

(40760409) HLA-A [Type] by High resolution

109

0.71

0.37

1.0

—

(40760410) HLA-B [Type] by High resolution

109

0.71

0.37

1.0

—

(46236302) HLA-C [Type] by High resolution typing

110

0.70

0.37

1.0

—

(40763590) HLA-DQ beta [Type]

110

0.70

0.37

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

597

1.11

0.36

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

597

1.11

0.36

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

182

1.22

0.36

1.0

—

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.44

0.35

1.0

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

280

1.17

0.35

1.1

2.23

1.65

umol/24h

1.78

280

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

236

0.82

0.35

2.8

3.6

2.10

2.21

mg/l

0.08

204

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.41

0.35

1.0

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

326

1.15

0.34

1.0

3.54

1.32

u/ml

0.29

243

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

131

1.25

0.33

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

155

1590

0.94

0.32

1.0

236.79

333.98

ng/l

3.47

114

1143

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

158

1.22

0.32

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

191

0.81

0.32

1.0

1.1

0.67

10.42

u/ml

0.48

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

115

1.26

0.31

14.9

15.9

—

(3009677) Dengue virus Ab [Presence] in Serum

137

0.77

0.31

1.1

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

168

1.20

0.30

1.3

—

(3020650) Glucose [Presence] in Urine

836

1.08

0.30

1.4

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.27

0.30

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

597

1.10

0.29

1.2

1.1

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

199

0.82

0.29

1.4

2.4

—

(3013762) Body weight Measured

105

0.73

0.29

1.0

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.23

0.29

1.4

1.1

2.57

2.44

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

656

0.91

0.28

1.1

1.3

—

(3041672) Baker's yeast Ab [Presence] in Serum

166

0.81

0.27

1.0

1.1

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

157

1598

0.95

0.27

1.0

31.94

42.17

ng/l

4.24

114

1128

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

157

1596

0.95

0.26

1.0

883.42

739.13

ng/l

3.29

112

1107

(3034614) HLA Ag [Interpretation]

1.30

0.26

1.0

1.3

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.28

0.24

1.0

—

(3018001) Oat IgE Ab [Units/volume] in Serum

245

0.86

0.23

1.0

0.05

0.81

u/ml

1.17

146

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

427

0.90

0.23

1.1

1.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

334

3115

1.03

0.23

1.5

—

(3003338) MCHC [Mass/volume]

26066

251507

0.99

0.22

24.5

15.5

330.11

332.84

g/l

307.65

25892

249758

(3026726) Creatinine [Moles/volume] in Specimen

211

1.14

0.22

2.5

235.88

407.02

umol/l

1.03

204

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3013851) Stachybotrys chartarum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(40761895) Polymorphonuclear cells/100 leukocytes in Peritoneal dialysis fluid

0.00

0.21

0.0

2.3

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

910

0.94

0.20

1.1

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

107

0.81

0.20

1.9

3.4

—

(4035726) Immunohistochemistry procedure

2389

23241

0.99

0.19

1.4

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

259

1.12

0.19

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

509

4794

1.02

0.19

1.1

3.35

2.87

u/ml

0.28

211

2441

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

510

1.08

0.19

4.3

5.9

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

189

0.87

0.18

1.2

0.15

5.84

u/ml

1.94

158

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

141

1.16

0.18

1.1

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.16

0.17

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.14

0.17

2.4

5.5

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

188

1.13

0.17

1.3

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

336

1.09

0.17

1.1

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

192

1910

0.97

0.16

1.1

1.0

0.39

1.01

u/ml

0.92

433

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

125

1.16

0.16

1.4

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

562

1.06

0.15

1.1

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

416

0.93

0.15

1.2

1.3

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.75

0.15

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.16

0.15

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

199

1.11

0.15

1.0

10.43

17.00

u/ml

0.61

166

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

563

0.94

0.14

1.7

1.9

1.94

3.54

ug/l

0.90

337

(42529582) MDA5 Ab [Presence] in Serum by Line blot

689

1.05

0.13

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

689

1.05

0.13

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

689

1.05

0.13

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

689

1.05

0.13

1.1

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

103

0.84

0.13

1.9

3.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

167

1.10

0.10

1.2

1.1

—

(40765096) Chromosome analysis panel by Banding

701

0.96

0.10

1.1

—

(3007700) Barley IgE Ab [Units/volume] in Serum

160

0.90

0.09

1.0

0.09

9.35

u/ml

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

534

0.96

0.09

1.5

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

177

1.09

0.09

1.0

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

423

1.05

0.08

2.1

2.0

—

(3036071) Salmonella sp Ab [Titer] in Serum

103

1020

0.97

0.08

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.83

0.08

1.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.83

0.08

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.83

0.07

1.3

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.84

0.07

4.3

3.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

314

0.95

0.07

2.8

2.7

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

186

0.93

0.06

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

214

2032

1.01

0.06

1.4

1.3

126.88

173.31

pmol/l

3.58

214

2032

(3045142) Bone marrow Pathology biopsy report

275

2679

0.99

0.05

1.3

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

106

0.91

0.05

1.5

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

204

0.94

0.05

1.0

1.1

9.19

6.68

u/ml

—

151

(3044416) Complement C4 [Mass/volume] in Pleural fluid

106

1.09

0.05

1.1

1.2

0.06

0.08

g/l

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

1.08

0.03

1.0

1.1

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

114

0.93

0.03

1.1

1.0

0.23

0.53

u/ml

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

184

1.05

0.03

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

386

1.02

0.02

2.0

1.6

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

118

1.06

0.02

1.1

1.0

0.09

0.31

u/ml

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

481

0.98

0.02

3.1

2.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

124

1202

0.99

0.01

3.2

3.0

—

(3007463) Buprenorphine [Presence] in Urine

148

1.04

0.01

8.6

7.3

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

189

0.97

0.01

1.2

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

159

1526

1.00

0.00

1.1

—

(3008607) Semen analysis panel

133

1.01

0.00

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

143

1377

1.00

0.00

5.7

5.9

4386.89

3024.12

u/ml

0.11

274

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

199

1.02

0.00

1.8

2.4

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

109

0.97

0.00

1.0

1.1

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

284

0.98

0.00

2.7

3.0

1.47

1.17

mg/l

0.30

191

(3013293) Extractable nuclear Ab [Presence] in Serum

468

1.01

0.00

1.6

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

290

1.00

0.00

1.3

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.95

0.00

1.0

1.2

—

(3017830) Gliadin IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

(3003220) Varicella zoster virus IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

571.80

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

-0.00

0.0

1.2

—

0.52

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.7

—

(3039621) Maximum lysis.intrinsic coagulation system activated.heparin insensitive [Length fraction] in Blood by Rotational TEG

0.00

-0.00

0.0

2.5

—

4.00

—

(3032642) Schistosoma sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3037820) Gliadin IgA Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

-0.00

0.0

4.0

—

141.00

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.3

—

(3012864) Amino acids [Identifier] in 24 hour Urine

0.00

-0.00

0.0

1.2

—

(3027114) Cholesterol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(43054952) inv(16)(p13.1;q22.1)(MYH11,CBFB) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

9.4

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: E4_OBESITY_HYPER – Obesity and other hyperalimentation

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Obesity and other hyperalimentation

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Obesity and other hyperalimentation (E4_OBESITY_HYPER)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints